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ABSTRACT

DEVELOPMENT OF POLYMER MONOLITHS FOR THE ANALYSIS OF
PEPTIDES AND PROTEINS

Binghe Gu
Department of Chemistry and Biochemistry
Doctor of Philosophy

Several novel polymer monoliths for the analysis of peptides and proteins were
synthesized using polyethylene glycol diacrylate (PEGDA) as crosslinker. Photo-initiated
copolymerization of polyethylene glycol methyl ether acrylate and PEGDA yielded an
inert monolith that could be used for size exclusion liquid chromatography of peptides
and proteins. This macroscopically uniform monolith did not shrink or swell in either
water or tetrahydrofuran. More importantly, it was found to resist adsorption of both
acidic and basic proteins in aqueous buffer without any organic solvent additives.
A strong cation-exchange polymer monolith was synthesized by copolymerization
of 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS) and PEGDA. A ternary
porogen (water, methanol and ethyl ether) was found suitable to prepare a flow-through
monolith with moderate pressure drop in aqueous buffer. The resulting monolith showed

excellent ion exchange capillary liquid chromatography of peptides using a simple salt
gradient. Extremely narrow peaks were obtained for the analysis of synthetic peptides,
natural peptides and a protein digest. A peak capacity of 179 was achieved.
Although the poly(AMPS) monolith demonstrated extraordinary performance,
one main drawback of this monolith was its relatively strong hydrophobicity. A decrease
in hydrophobicity was achieved by using more hydrophilic monomers (e.g., sulfoethyl
methacrylate or vinyl sulfonic acid). The most hydrophilic poly(vinyl sulfonic acid)
monolith provided high resolution cation-exchange liquid chromatography of protein
standards and lipoproteins. Use of the new PEGDA biocompatible crosslinker over the
conventional ethylene glycol dimethacrylate crosslinker for the preparation of polymer
monoliths was found to be advantageous for the analysis of biological compounds in
several chromatography modes.
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CHAPTER 1 BACKGROUND AND SIGNIFICANCE

1.1 Proteomics
After approximately 13 years of extensive research, a working draft of the human
genome was decoded.1-3 This was a great achievement towards the understanding of the
complexity of human biology. The human genome is believed to be a rich source of
information for a variety of purposes, such as disease diagnosis, early detection of geneic
pre-dispositions to diseases, gene therapy, and rational drug design, including
pharmacogenomic custom drugs. However, the true complexity of human biology is at
the level of proteins, not genes. This is because protein diversity cannot be fully
characterized by gene expression analysis alone, primarily due to alternative splicing and
posttranslational modification of proteins. For example, it is estimated that approximately
1,500,000 different proteins exist in the human body while the total gene count in the
human body is around 22,000.4,5 Furthermore, the raw genetic sequence cannot predict a
protein’s function and expression level in different cells. Thus, the analysis of proteins is
the next key step to understand the complexity of human biology. The term, “proteome”,
was coined in analogy to genome by Wilkins et al. in 1996.6 Proteomics is a term that
refers to the characterization of all proteins expressed by a group of active genes in a
given cell or tissue.7
The analysis of the human proteome is an extremely challenging task due to the
large number of proteins present in the human body. Moreover, marker proteins, whose

1

expressions change during the progression of a disease or under drug treatment, are the
targeted proteins to be analyzed. Most of these proteins exist at trace levels, while other
more abundant proteins interfere with detection. Therefore, techniques that can handle a
very broad concentration dynamic range are required for proteomics studies.
Currently, the most popular method for resolving a large number of proteins is
two-dimensional (2-D) gel electrophoresis.8 This technique separates proteins based on
their isoelectric points in the first dimension, and molecular weights using denaturing gel
electrophoresis in the second dimension. The combination of these two orthogonal
techniques can resolve up to 10,000 proteins, making 2-D gel electrophoresis a very
powerful technique for profiling proteins in human body fluids.9-12 With the recent
development of MALDI and ESI mass spectrometry, the identification of proteins in a 2D gel has become a less demanding task, further increasing the popularity of 2-D gel
electrophoresis in proteomics research.13-16 Although very successful for proteomics, 2-D
gel electrophoresis suffers some limitations. The most serious problem is its inability to
detect low abundance proteins,17,18 although some controversy exists.19 This aspect is
particularly problematic because most proteins of interest are in the trace level range. In
addition, 2-D gel electrophoresis can be problematic in the detection of very hydrophobic
and/or basic proteins.17 It is also labor-intensive and time-consuming. These limitations
make it necessary to develop alternative or complementary techniques for proteomics.
Liquid chromatography (LC) is one of the most promising methods, and it will be
outlined in the following section.
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1.2 Liquid Chromatography in Proteomics
Due to its high resolving power, excellent reproducibility, online preconcentration
capability, ability of detecting both hydrophilic and hydrophobic proteins/peptides, and
ease of interfacing with mass spectrometry (MS), high performance liquid
chromatography (HPLC) has gained increasing interest in proteomics studies.20 Two
basic methodologies have been proposed for the use of LC in proteomics research. The
first is a “top-down” approach in which proteins are separated first, followed by
enzymatic digestion (e.g., tryptic digestion) of the separated proteins and subsequent
identification by peptide profile mapping.21 The other is the “bottom-up” approach, also
called “shotgun” proteomics. In this method, all proteins in a sample are digested first,
followed by separation of peptides and subsequent identification of the original proteins
by software searching.22 In both cases, separation by chromatography plays a key role in
the analysis of proteins.
1.2.1

Reversed-phase LC of Proteins
At present, most LC of proteins is performed using the reversed-phase (RP) mode

of chromatography coupled with MS for detection and identification. This is mainly due
to the compatibility of RP LC with MS. In RP LC, samples can be easily desalted, and
water and water-miscible volatile organic solvents are typically used as mobile phases.
Although conventional RP LC has been applied in proteomics studies, an improvement in
resolution and peak capacity is required due to the complexities of proteomic samples.
Several approaches have been proposed for using RP LC for proteomics research. These
include ultrahigh pressure liquid chromatography,23-26 accurate mass tag measurement by
high resolution MS,27-28 and elution-modified displacement chromatography.29,30
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With ultrahigh pressure equipment in LC, small particles can be used, resulting in
high column efficiency and high resolution. For example, efficiencies up to 570,000
plates/m were obtained using 1.5 µm nonporous silica particles under a column backpressure of 20,000 psi.23 The high efficiency achieved by ultrahigh pressure LC has been
extended to proteomics research. Shen et al. used 3 µm particles packed in a fused silica
capillary for the analysis of soluble yeast proteins, and obtained a peak capacity of 1,000
at a column pressure of 10,000 psi.25 Further improvement in sensitivity was achieved by
the same group by incorporating micro solid-phase extraction, enabling analysis of ng
protein samples.26
Another elegant approach to facilitate the identification of proteins is to use the
so-called “accurate mass tag” (AMT) technique. This is based on the concept that a
protein can be theoretically identified by detection of several unique peptides by tandem
MS, provided that unambiguous detection of the peptides of interest can be made. Using
high resolution Fourier-transform ion cyclotron resonance MS, it is feasible to resolve a
mass difference of 1 ppm, which makes possible the accurate mass measurement of such
unique peptides.27 The AMT approach has been successfully applied to the analysis of
Saccharomyces cerevisiae, Caenorhabditis elegans, and Deinococus radiodurans
proteomes.27,28 A high coverage (61%) of proteins was reported using the AMT method.28
Another unique RP LC approach for proteomics is to use elution-modified
displacement chromatography.29,30 The main advantage of displacement chromatography
over conventional linear elution chromatography is the characteristic enrichment of low
abundance analytes. For example, trace marker peptides were detected in the fmol range
in a model study of the rhGH proteome.29,30 Another favorable feature is relatively fast
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analysis since enrichment and separation are performed at the same time. One main
disadvantage of this novel technique is the requirement of large amount of sample, which
is often difficult to obtain in proteomics.
1.2.2

Two-Dimensional LC
Although RP LC has achieved some success in certain proteomic studies (vide

supra), the peak capacity is insufficient to resolve most extremely complex proteome
samples. One method to dramatically improve peak capacity is to use 2-D or multidimensional LC modes, where overall peak capacity is the product of the peak capacities
in each dimension.31-34 For proteomics studies, the second dimension is typically a RP
mode directly coupled with MS. The first dimension, which should be an orthogonal
mode to RPLC, could be ion-exchange (IE), affinity, or size exclusion chromatography
(SEC). The most widely used combination is IE-RP LC coupled to MS. For example,
using 2-D IE-RP LC with column switching, a total peak capacity of 600 was achieved
for the separation of complex protein mixtures.35 This approach was applied to human
brain glioma cells and the A431 epidermal cancer cell proteome, leading to the
identification of 213 and 280 proteins, respectively.36,37 Recently, a remarkable 1504
proteins were identified in the yeast proteome using the IE-RP LC approach.38 Similarly,
490 proteins were detected in human blood serum by combining IE and RP LC.39
In the IE-RP LC combination, each fraction of the first dimension would be either
collected and injected offline to the second RP column, or online to the second dimension
by column switching. Sometimes, a trapping column before the second dimension is
required for desalting, preconcentration, and injection to the second dimension. A main
disadvantage of this approach is that it is time-consuming. It may take several hours or
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days to complete the IE-RP run. An elegant approach, termed “multi-dimensional protein
identification technology” (Mud-PIT), was introduced to run the 2-D separation in
relatively short time.22,40 In this method, a single capillary column was packed with IE
silica particles in one section and RP silica particles in another section in tandem.
Although not strictly comprehensive 2-D, Yates’ group used this approach and identified
a remarkable 1484 proteins in the yeast proteome.40 The Mud-PIT approach was also
proven useful for the identification of membrane proteins from crude rat brain
homogenate.41
In addition to IE as the first dimension in 2-D chromatography of a proteome,
affinity or SEC is also used for specific applications. Due to the strong binding between
antibody and antigen, affinity chromatography is particularly useful for preconcentration
of low abundance analytes. It is well known that posttranslational modifications of
proteins, such as phosphoration and glycosylation, are very common and play important
roles in the behavior and interactions of cellular proteins. Such modified proteins often
exist at very low concentrations and, thus, are difficult to identify in complex mixtures
containing highly abundant proteins. Immobilized metal affinity chromatography
(IMAC)42,43 and immunoaffinity chromatography (IAC)44,45 are useful for trapping
phosphopeptides. Lectin affinity chromatography (LAC) is applicable to the analysis of
glycoproteins. In IMAC, a transition metal, such as Fe(III) or Ga(III) ions, is immobilized
in the stationary phase and used to selectively isolate and concentrate phosphopeptides
due to high affinity binding between the transition metal and serine, threonine or tyrosine
in the phosphopeptides. Using the IMAC approach, analysis of bovine casein at the level
of 30 pmol was achieved.42 IAC is similar to IMAC except that an antibody (e.g.,
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antiserine, antithreonine or antityrosine) rather than a transition metal is used to capture
the phosphopeptides. Because antibody-antigen interaction is typically stronger than
metal chelating interaction, the selectivity and preconcentration factors of IAC are better
than IMAC.44,45 For the analysis of glycoproteins, LAC has proven to be one of the most
powerful techniques to isolate and enrich specific classes of glycoproteins based on the
lectin ligands used.46,47 Xiong et al. used LAC coupled with RPLC to study
lymphosarcoma in dogs, and identified two proteins that are related to cell adhesion and
cancer cell migration.46
SEC has also been used as the first dimension in 2-D LC for proteomics research,
although little attention has been paid to this mode. This is probably due to the low
resolving power and low loading capacity of SEC. However, since separation in SEC is
determined by protein size, a feature similar to the second dimension in 2-D gel
electrophoresis, it should be very useful for fractionating proteins. Several reports have
been found using SEC-RP LC for proteomics studies.48-50
The previously described studies confirmed the power of the 2-D approach, and
addressed some of the limitations of conventional protein analysis techniques, such as
reproducibility, automation, and convenience in interfacing with MS. However, much
remains to be done to further improve the capabilities of current separation media and
techniques to meet the needs of proteomics. Most techniques described above utilized
packed columns, i.e., columns packed with µm-size spherical particles. To prepare such
columns requires multiple steps, starting with the synthesis of small spherical particles,
followed by sieving and introduction of functionality by chemical derivatization. Finally,
the particles are packed into a chromatographic column and retaining frits are fabricated.
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Especially for proteomics studies in which capillary columns are used to improve mass
sensitivity, packing of the column is a tedious process, and frits are hard to make
reproducibly. Another more fundamental limitation of packed columns is that they have
large void volume. Even the best packed columns have ~40% external porosity. The
existence of such large external porosity limits the speed of chromatography due to the
resistance to mass transfer. As commented on by Regnier, the most significant advances
in HPLC have always followed the introduction of enhanced support matrices.51 Nearly
20 years ago, a novel chromatographic support, called a monolith, was introduced to
overcome some of the limitations of packed columns and to achieve fast separations.52,53
In the following sections, monolith technologies will be reviewed in detail.
1.3 Introduction to Monoliths
HPLC became available only after the introduction of microparticulate porous
silica particles in the 1960s.54,55 However, it has been proven difficult to apply HPLC to
the chromatography of macromolecules with conventional microporous particles. The
limiting factor in chromatography of macromolecules is the mass transfer resistance due
to the small diffusion coefficients of macromolecules. This results in both low column
efficiency and limited speed of analysis. Biomolecules were first separated in HPLC in
the mid 1970s only when macroporous silica particles became available (see reviews 56
and 57). Further improvements in the HPLC of macromolecules were achieved with the
availability of hydrophilic rigid organic resins.58-60 To alleviate mass transfer resistance
for fast separation of macromolecules, more advanced separation media have been
introduced, which include nonporous particles,61 hybrid separation media62 and perfusive
beads.63 The highly original perfusive beads introduced by Regnier’s group allow a small
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portion of the mobile phase to flow through the pores of the beads.63 This convective
flow greatly enhances the mass transfer of macromolecules, resulting in a significant
improvement in the speed and chromatographic efficiency for macromolecules. It is
natural to anticipate that further improvements will be achieved if all of the mobile phase
is forced to flow through the separation media. Realizing that this approach was not
realistic for packed columns, led to the development of membrane chromatography.64-66
Another reason for the rapid development of membrane chromatography was the finding
that proteins could be separated using very short columns. In fact, a membrane can be
viewed as a column with extremely short length and large diameter. The introduction of
membrane chromatography enabled the rapid and extremely fast separation of
biopolymers.65 Several other alternatives to a membrane have also been introduced and
used as chromatographic supports. These include cellulose sheets,67 woven fabrics68 and
macroporous discs.69 However, they have not gained widespread application mainly due
to fabrication difficulties and lack of suitable accessories for sample introduction.
Although fast separation can be achieved using membrane chromatography, one
limitation of a membrane is the low sample loading capacity per unit volume compared to
porous particles. Around the year 1990, monolith technologies were introduced as novel
chromatographic supports by two groups independently.52,53 A monolith, originally called
a continuous polymer bed,52 is a continuous rod with canal-like µm-sized through-pores
and nm-sized pores in its skeletal structure. At first glance, a monolith appears to be
analogous to a membrane, except that a monolith has a longer length and smaller
diameter. In fact, these two media have great differences. A membrane does not have
distinct through-pores and nanopores. Furthermore, the specific loadabilty of a monolith
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is much greater than a membrane. Monolithic columns have received considerable
interest due to their favorable features, such as ease of preparation, abundance of
functional group chemistries available and, most importantly, enhanced mass transfer.
After approximately 17 years of study, monoliths have become key alternatives to packed
beds. Guichon once commented that “the invention and development of monolithic
columns is a major technological change in column technology, indeed the first original
breakthrough to have occurred in this area since Tswett invented chromatography, a
century ago.”70 Iberber also called the monolith the 4th generation of chromatographic
sorbent for the analysis of biomolecules.71
1.3.1

History of Monoliths in Chromatography
The first article that describes the preparation of a monolith for use in

chromatography can be dated back to 1967.72 The synthesis of this monolith was done
using a molding process. An aqueous solution of 2-hydroxyethyl methacrylate (HEMA)
with 0.2% ethylene glycol dimethacrylate (EDMA, as a crosslinker) was introduced into
a glass tube (22 cm × 23.5 mm i.d.). After free radical polymerization, a highly swollen
polymer hydrogel with a continuous structure was obtained and used in size exclusion
chromatography of water soluble polymers. Due to significant swelling and tendency to
be compressed upon applying pressure, chromatography was performed using gravity. As
a result, a very low mobile phase flow rate (only 4 mL/h) was used, which in turn
resulted in low column efficiency due to excessive longitudinal diffusion. The low
permeability of the column was primarily due to the use of a very low amount of
crosslinker (only 0.2%). Nevertheless, this was the first attempt to prepare a polymer
monolith for use in chromatography.
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Several years later, monoliths with improved permeability were obtained using
polyurethane chemistry.73-77 In contrast to the swollen poly(HEMA) gel reported above,
the continuous polyurethane monolithic columns maintained their permanent
macroporous structure even in the dry state. These columns have been demonstrated in
both GC73-76 and LC73,77 modes. Unfortunately, inferior chromatographic performance of
these columns prevented their wide acceptance, presumably due to swelling and softness
in some solvents.
Two decades passed before modern monoliths were successfully introduced,
which competed favorably with packed columns.52,53 The first was based on
polyacrylamide.52 In this approach, acrylic acid and bisacrylamide were copolymerized in
a stainless steel column with the use of redox initiation (N,N,N’,N’tetramethylethylenediamine, TEMED and ammonium peroxosulfate, APS). After
polymerization, the monolith was compressed by applying a high pressure using an
HPLC pump. This step was important to produce a uniform/homogeneous bed to improve
column efficiency and resolution. Fast and efficient separation of several model proteins
was demonstrated using cation-exchange chromatography. An interesting finding about
this monolithic column was that resolution increased with an increase in mobile phase
flow rate.
In contrast to the soft polyacrylamide based monolith, a rigid monolith based on
methacrylate polymers was introduced in 1992.53 In this approach, glycidyl methacrylate
(GMA) was used as monomer and EDMA was used as crosslinker. The monomer
solution also contained a large amount (60%) cyclohexanol and dodecanol as porogens
(pore-forming agents), and 1% 2,2’-azobisisobutyronitrile (AIBN) as initiator. Using
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thermally initiated polymerization, a rigid polymer monolith with a high degree of
crosslinking was formed inside a stainless steel column. Tetrahydrofuran (THF) was
pumped through the resulting monolith to flush out porogens and any unreacted
monomers. The epoxide group in the monolith was subsequently reacted with
diethylamine to produce an anion-exchange monolith for protein analysis. Comparable
chromatographic performance to packed columns was obtained using this type of
monolith.
Following the introduction of the polymer monolith, silica monoliths were also
synthesized using sol-gel chemistry several years later.78,79 In contrast to the typical onestep in-situ preparation of polymer monoliths, the synthesis of a silica monolith often
requires multiple steps. Another feature of silica monoliths is that they are mostly applied
to the analysis of small molecules.
1.3.2

Preparation of Polymer Monoliths
The preparation of polymer monoliths is often a one-step in-situ process, typically

via free radical polymerization. Several initiation techniques have been developed to
prepare monoliths in different molds for specific applications. In addition, surface
chemistry (functionality) can be easily controlled in polymer monoliths. Since a onephase transparent monomer solution is the starting point to prepare a monolith, both
hydrophilic and hydrophobic monomers can be used by choosing appropriate porogens.
Chemical derivatization of some reactive monoliths (e.g., GMA) increases the range of
available functionalities dramatically. More importantly, the recently introduced grafting
technique allows nearly unlimited introduction of a variety of surface functionalities.
Furthermore, the porosity of the polymer monolith can be controlled by varying the
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components in the monomer solution as well as by using different initiation techniques.
This characteristic is particularly important for fast separation in that a monolith with
very high permeability can be easily prepared while maintaining good chromatographic
performance. Finally, the crosslinker is equally important in the design and preparation of
polymer monoliths. Because crosslinker to total monomer ratio is typically in the range of
30-70 wt%, the crosslinker will affect both the mechanical strength and the backbone
polarity of the resulting monolith.
Initiation of polymerization. The early development of polymer monoliths
followed analytical packed column technology in which stainless steel tubing with i.d. of
4.6 mm is typically used. As a result, thermal initiation dominated the preparation of
polymer monoliths. For example, the first successful poly(GMA) monolith was prepared
in a stainless steel tube via thermal initiation.53 The thermal initiator AIBN is widely used
in the preparation of polymer monoliths. Upon heating at ~60 ºC, AIBN decomposes to
form free radicals (Figure 1.1), which can initiate the polymerization of most vinylcontaining monomers. Because the decomposition temperature is low, any solvent with
boiling point above 60 ºC can potentially be used as a porogen to prepare the monoliths.
The most widely used and effective porogens for the preparation of polymer monoliths
are either long-chain alcohols53,80-82 (e.g., cyclohexanol and dodecanol) or short chain
alcohols83-85 (e.g., 1-propanol and 1,4-butanediol). In addition to AIBN, benzoyl peroxide
has been used as a thermal initiator for monolith preparation, although it has not been
very popular.81
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Besides the conventional AIBN thermal initiator, stable free radical initiators
were also introduced to synthesize novel monoliths with “living” surface properties. For
example, 2,2,6,6-tetramethylpiperidyl-1-oxy (TEMPO) has been used as initiator to
initiate the copolymerization of styrene and divinylbenzene.86 In contrast to AIBN or
benzoyl peroxide where 55~80 ºC is sufficient to form initiator radicals, a higher
temperature of 130 ºC is required to decompose TEMPO. As a result of the slow
initiation of TEMPO, quite different monolith morphology with very high surface area
was obtained, which could be potentially used in size exclusion chromatography of
synthetic polymers. Although TEMPO-initiated polymerization resulted in a monolith
with high surface area (300 m2/g), the permeability of the resulting monolith was low.
Further improvement of flow-through properties was achieved by using other stable free
radicals or a mixture of them. 3-Carboxy-2,2,5,5-tetramethylpyrrolidinyl-1-oxy and 4carboxy-2,2,6,6-tetramethylpiperidinyl-1-oxy have been used to prepare polystyrene
monoliths with a through-pore medium diameter of 1 µm, thus enabling fast flow under
moderate column backpressure.87 The main advantage of using a stable free radical
initiator is the ease of post-column modification. After polymerization, there are still
“living” free radicals on the surface of the resulting monolith, which can be used to graft
other vinyl-containing monomers. In this approach, it is straightforward to introduce new
surface chemistries from the same bulk monolith that has optimized mechanical
properties.
Another unique branch of polymer monolith can be prepared via ring-opening
metathesis polymerization (ROMP).88,89 Here, the initiator, more accurately called a
catalyst, is a transition metal complex (e.g., a Grubbs-type catalyst with a general formula
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of Cl2(PR3)2Ru(=CHPh), R = phenyl or cyclohexyl). Polymerization is performed at low
temperature (<0 ºC ) and under an inert environment (nitrogen protection). Monomers are
cycloolefins, and crosslinkers are olefins with two or more vinyl groups in two or more
rings. The unique property of ROMP is that polymer chain growth is via ring opening
while vinyl groups remain intact. Another feature of ROMP is its “living” characteristic.
After polymerization, the initiator is still active on the surface of the polymer, which
allows flexible grafting of various chromatographic ligands. Buchmeiser’s group
pioneered the preparation of polynorbornene-based monoliths using the ROMP approach.
Several chromatographic modes including RP, IE and chiral recognition have been
demonstrated. 88,89
With the recent burgeoning interest in proteomics research, the capillary column
has received more attention due to increased mass sensitivity. Another trend is the
development of monoliths for use in planar microchip formats.90 Both of these factors
have led to the development of photoinitiation for the preparation of polymer monoliths.
For photoinitiation, the most widely used initiator is 2,2-dimethoxy-2phenylacetophenone (DMPA). Upon UV irradiation at 365 nm, DMPA decomposes into
three radicals that subsequently initiate the polymerization of vinyl-containing monomers
(Figure 1.2).
Several requirements must be followed for the use of photoinitiation. First, a mold
that is UV transparent is required. Fluoropolymer-coated fused silica, quartz, and glass
microchips fulfill this requirement. In addition, porogens must not absorb UV radiation in
any significant degree. Fortunately, the UV transparency requirement is satisfied by most
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organic solvents that would be selected for use. Finally, the diameter must be sufficiently
small that UV radiation can penetrate the whole diameter of the mold. Capillaries with i.d.
smaller than 320 µm and most microchips can be safely used. Despite the limitations
described above, photoinitiation has several distinct advantages, which have spurred its
rapid development.91-101 Probably, the most important characteristic is the improvement
in monolith uniformity over heat initiation. It is well known that free radical
polymerization is an exothermic process. Using thermal polymerization, the heat
generated cannot dissipate well, resulting in a temperature gradient along the radial
direction of the tube (higher in the center than periphery). Because the morphology of the
monolith, such as surface area and through-pore diameter, is very sensitive to the
temperature,82 the temperature gradient under thermal initiation leads to nonuniformity,
which in turn affects column efficiency.
In addition, another attractive feature of photoinitiation is the selective patterning
of monoliths in desired regions. Polymerization occurs only in the region that is exposed
to UV irradiation. Using a suitable UV mask, a monolith with advanced pattern can be
obtained. For example, a capillary with dual functionalities has been prepared for peptide
mapping using suitable masks.95,98 Photoinitiation is especially suited to microchip
applications.90,93 In a microchip, the functional monolith is ideally placed only in the
separation channel, while reservoirs and injection channels are void of monolith. This
geometry is hard, if not impossible, to achieve using other types of initiation. Third,
photoinitiation operates much faster than thermal initiation. Complete conversion of
monomers to polymer can occur in minutes using photoinitiation, in sharp contrast to >20
h using thermal initiation.94,95, 99-101 The fast reaction rate using photopolymerization is
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very useful in the optimization of the monolith. It is not uncommon that an acceptable
recipe results only after hundreds of screening experiments. Finally, since photoinitiated
polymerization is performed at room temperature, low boiling point organic solvents,
such as methanol and ethyl ether,99-101 can be safely used as porogens. This adds more
control over the adjustment of the pore size distribution of a monolith, which is a key
property of a monolith for use in flow-through applications.
Due to the polarity of acrylamide-based monomers, redox initiation is often used
for the preparation of acrylamide-based monoliths.52,102 For this initiation technique, APS
and TEMED have been used as initiators (Figure 1.3). Polymerization using this redox
system occurs at room temperature. The APS-TEMED system has also been used to
prepare polymethacrylate monoliths, although this is not well recognized as an alternative
to the widely used thermal initiation.103
A less common initiation technique using a high energy irradiation source (e.g., γradiation) was reported recently for the preparation of polymethacrylate monoliths.104
High energy irradiation breaks down chemical bonds (e.g., C-H bonds), yielding a radical
that can be used to initiate the polymerization of vinyl-containing monomers. This
process is similar to UV initiated photografting (vide infra) for which deep UV (e.g., 210
nm) is typically used, except that high energy (γ-radiation) is used. Thus, the radiation
can penetrate deeply into the monomer, making it possible to prepare up to 4 mm
diameter monoliths. Other advantages of high energy radiation initiation include fast
reaction rate and no chemical initiator required. The main disadvantage, however, is the
extremely dangerous γ-radiation, making it difficult to perform in conventional
laboratories.
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Functionalization of the monolith surface. Three methods have been developed
for the introduction of functionalities during the synthesis of polymer monoliths. The
widely used, originally adopted, and still most popular one is copolymerization. During
the 17 years of development of the monoliths, numerous examples can be found using
copolymerization to introduce desirable chemistry. For some monomers that are not
readily available or difficult to synthesize, chemical derivatization of some bulk reactive
monolith (e.g., GMA) introduces new surface chemistry. This approach is particularly
useful in affinity chromatography and enzyme immobilization. Actually, derivatization is
a well established method to prepare silica-based particles used in conventional
HPLC.54,55 For example, monodisperse bare silica particles are prepared and silanized
with alkylsilanes to generate reversed-phase particles. The third approach, grafting, is
another powerful method to introduce new chemistries. In particular, grafting by deep
UV has recently gained in popularity.94-96,98
Numerous functional monomers have been used to prepare polymer monoliths via
copolymerization, which include hydrophilic, hydrophobic, reactive and ionizable
monomers. Typical hydrophilic monomers include acrylamide, N-isopropylacrylamide,
N-ethylacrylamide or their methacrylamide analogs, HEMA and polyethylene glycol
methyl ether acrylate (PEGMEA). Hydrophobic monomers mainly comprise butyl
methacrylate (BMA) or butyl acrylate (BA), and styrene as well as norbornene. The
widely used reactive monomer is GMA or chloromethylstyrene, or 2-vinyl-4,4dimethylazlactone (VAL). Ionizable monomers include 2-acrylamido-2-methyl-1propane sulfonic acid (AMPS), 2-acryloyloxyethyltrimethylammonium chloride (AETC)
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or 2-methacryloyloxyethyltrimethylammonium chloride (METC). The chemical
structures of the monomers described above are shown in Figure 1.4.
In addition to copolymerization, chemical derivatization is another powerful
method to introduce new surface functionality. Among the three reactive monomers,
GMA has gained the most widespread application. The epoxide group in the poly(GMA)
monolith can be potentially attacked by any nucleophiles, such as amines or amino
groups in proteins or sodium sulfite. For example, the first polymethacrylate monolith
was based on GMA.53 After the epoxide was reacted with diethylamine,
diethylaminoethyl chemistry was introduced, which was successfully used for anion
exchange chromatography of acidic proteins. The reactive epoxide can also be modified
with sodium sulfite to generate a cation-exchange monolith. For example, Ueki et al. has
used this approach for strong cation-exchange chromatography of inorganic cations.105
The more useful function of the poly(GMA) monolith is for immobilization of enzymes
(e.g., trypsin) for preparation of microbioreactors. Immobilization of enzymes can be
achieved by direct reaction of the enzyme with poly(GMA), or by inserting an arm
between poly(GMA) and the enzyme. A detailed review on using poly(GMA) to
immobilize enzymes has been recently published.106
Grafting of a functional monomer has several advantages as compared to either
copolymerization or derivatization. First, only one optimization process is sufficient. In
the grafting approach, a generic monolith [e.g., poly(BMA)] with good mechanical
strength and flow properties is prepared and optimized. Then a new monomer (e.g., those
shown in Figure 1.4) with suitable initiator is loaded into the pores of the general
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polymer monoliths in copolymerization.
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monolith and grafted on the surface of the monolith. Thus, different chemistries can be
introduced through one general monolith. This feature is very attractive. The optimization
of a new monolith is a time-consuming process. Although some theoretical aspects of the
preparation of macroporous particles have been proposed,107-109 the main approach to
optimize a new monolith system is via trial-and-error at the present. By grafting, tedious
optimization of each of the new monomers is avoided. Second, a better surface coverage
is expected as compared with copolymerization. Because grafting occurs from the
monolith surface and extends into the pores of the monolith, all of the functionalities are
accessible for interaction. Furthermore, the grafted chains can also serve as new loci from
which new chains can grow, ultimately leading to a highly branched structure. This
further increases the binding capacity of the resulting monolith. Finally, grafting is
typically fast, and the degree of grafting can be easily controlled.
Grafting can be realized in several ways. First, the nature of the ROMP method
determines the ease of surface grafting.88,110 Because the initiator is attached to the
surface of the resulting monolith after polymerization, grafting can be initiated after the
introduction of a new cycloolefin. A variety of functionalities such as carboxylic acid,
tertiary amine and cyclodextrin, have been grafted into a base polynorbornene monolith.
Second, grafting can be achieved via the use of stable free radicals (SFR).86,87 This
approach is very similar to the ROMP method. SFR on the surface of the monolith can be
activated upon heating, and they initiate the graft polymerization of new monomers. For
example, chloromethylstyrene and vinylpyridine have been successfully grafted to
polystyrene monoliths.111 Third, grafting is performed through the immobilization of
initiators. This approach is similar to the ROMP and SFR methods; however, it is not a
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universal method. To immobilize an initiator on the surface of a monolith, the bulk
monolith should be reactive. For example, Tripp et al. immobilized a free radical azo
initiator through the reaction of 4,4’-azobis(4-cyanovaleric acid) with the chloromethyl
functionality in the polychloromethylstyrene monolith.112,113 This free radical initiator
was used to graft VAL onto the monolith to separate amines. Fourth, grafting is achieved
by the introduction of vinyl-containing chemicals. This is not a universal approach, either.
For the poly(GMA) monolith, allylamine can be reacted with the epoxide group to form a
pendant vinyl group. If one adds a new monomer solution with initiator, grafting from the
vinyl group in the poly(GMA) monolith will occur. Peters et al. used this approach to
graft N-isopropylacrylamide, and obtained a unique monolith that was thermally
responsive.114 The hydrophobicity of this grafted monolith changes from hydrophilic to
hydrophobic upon an increase in temperature. Finally, grafting is realized via UV
irradiation. This is a universal approach and very popular today. If a polymer is irradiated
with deep UV (e.g., < 200 nm), hydrogen abstraction occurs, leaving an active radical on
the polymer surface.115,116 Using this approach, AMPS, VAL and BMA have been grafted
onto the poly(BMA) monolith.94,96 Furthermore, N,N-dimethyl-N-methacryloyloxy-ethylN-(3-sulfopropyl)ammonium betaine (SPE) has been grafted onto the same poly(BMA)
monolith for rapid and efficient separation of proteins in capillary
electrochromatography.117

Control of monolith porosity. In flow-through applications, such as
chromatography, online enzyme microreactor, and online solid phase extraction, both
large surface area and good permeability are desirable. A large surface area provides
more active sites for effective interactions, and good permeability allows faster
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processing and low back-pressure. For polymeric monolithic columns, the surface area is
mainly determined by the nanopores (<2 nm) and mesopores (between 2 and 50 nm),
while the macropores (>50 nm) provide little contribution. The permeability, on the other
hand, is mainly determined by the average diameter of the macropores (through-pores).
Unfortunately, in most cases, a monolith with good permeability typically has low
surface area, and vice versa. Thus, a balance must be met between surface area and flowthrough properties. This requires the optimization of the pore size distribution to fit each
application.
The pore size distribution of a polymer monolith can be adjusted by several
variables. These include initiator concentration, total monomer to total porogen ratio,
monomer to crosslinker ratio, porogen nature and ratio of porogens if more than one
porogen is used. Although a decrease in initiator can decrease the pressure drop of the
monolith, a longer time is required to complete the polymerization. A decrease in total
monomer to total porogen ratio is a straightforward method to decrease the pressure drop
of the monolith; however, it decreases the homogeneity and rigidity of the monolith as
well. A change in monomer to crosslinker ratio can have an effect on the pressure drop of
the resulting monolith, although it also changes the rigidity and homogeneity of the
monolith. The most powerful factor to control the pressure drop of the monolith is the
selection of porogens since they do not affect the composition and rigidity of the
monolith.
The selection of porogen(s) is unlimited. Good solvent, poor solvent and linear
polymers have proven useful for the preparation of macroreticular polymer resins in
suspension polymerization.107-109 The combination of good solvent, poor solvent and/or
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linear polymer is also effective in preparing polymer monoliths. There are several
requirements for the design and selection of porogens. First, they must dissolve all
reagent components (i.e., initiator, monomer and crosslinker). A transparent monomer
solution is a prerequisite for developing a good monolith. Second, the polarity of the
porogen must be easily adjustable. Porogens generally include both a good solvent and a
poor one. In this way, porogen mixtures with different solvent strengths can be obtained
by varying the ratio between the good and poor solvents. This is particularly important
because it controls the onset of phase separation (i.e., polymer chain precipitation from
the porogens as it grows longer), which determines the pore size distribution of the
resulting monolith. In general, good solvents will generate a monolith with small
through-pores due to later onset of phase separation. Poor solvents, on the other hand,
yield monoliths with large through-pores, resulting in good permeability. Finally, the
porogen must be compatible with the initiation technique. Depending on the initiation
technique used, different organic solvents have been used for monolith synthesis (see
Section 1.3.2). For example, in thermal initiation, low boiling point solvents will not
work as porogens. Similarly, only UV transparent solvents can be utilized if
photoinitiation is used.
In addition to common organic solvents as porogens, linear polymers can also
work as porogens. For example, polyethylene glycol (PEG) of different molecular
weights has been used as porogen to prepare polyacrylamide monoliths.117 A systematic
study using PEG as coporogen has also appeared recently for the preparation of
polymethacrylate monoliths for hydrophobic interaction chromatography of proteins.118
Another atypical porogen is supercritical carbon dioxide. This porogen is attractive in
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that it is nontoxic, nonflammable and inexpensive. Furthermore, the solvating power can
be adjusted by applying different pressures. Thus, supercritical carbon dioxide itself
rather than a mixture of solvents can effectively work as porogen, making optimization
somewhat straightforward. Using EDMA and trimethylolpropane trimethacrylate (TRIM)
as model monomers, monoliths with a broad range of through-pore diameters (20 nm - 8

µm) have been prepared.119,120
Among all types of polymer monoliths developed, the polyacrylamide monolith is
unique. In addition to the common porogen approach to control the pore size
distribution,117,121 ionic strength is another powerful method to adjust the through-pore
diameter.52,102 In this approach, no organic solvents are required. The monomer mixture
is a transparent aqueous solution. The formation of through-pores is achieved by
promoted hydrophobic interaction of the polymer backbone in the presence of a high
concentration of salt (e.g., ammonium sulfate). For polyacrylamide monoliths containing
hydrophobic ligands, a surfactant is often used to emulsify the monomer mixture, and the
same principle can be applied to control the formation of through-pores.102

Crosslinking during monolith polymerization. In contrast to various monomers
used for preparation of polymer monoliths,52,53,80,88,121-124 the number of crosslinkers is
much more limited. Very little effort has been directed toward study of crosslinker effects
on chromatographic performance. This is quite surprising since the crosslinker is an
integral part of the resulting monolith, typically accounting for 30-70% by weight. As a
result, the crosslinker should be expected to significantly affect both the rigidity of the
resulting monolith and its overall polarity.
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In Chapter 2, I report a new crosslinker, polyethylene glycol diacrylate (PEGDA),
for the preparation of acrylate-based polymer monoliths for aqueous SEC of peptides and
proteins.99 The PEGDA crosslinker demonstrated superior biocompatibility compared to
conventional ethylene glycol dimethacrylate. At the same time, several other crosslinkers,
including polyethylene glycol dimethacrylate, were copolymerized with BMA for RPLC
of proteins.125 Although the advantage of biocompatibility of the crosslinker was not
demonstrated in these studies due to the use of the RP mode of chromatography;
nevertheless, the feasibility of using crosslinkers other than conventional EDMA to
prepare methacrylate-based polymer monoliths was clearly shown.
For analysis of biological samples, such as peptides and proteins, the use of
PEGDA is helpful to suppress nonspecific interactions. As shown in Figure 1.5, PEGDA
has an acrylate group at each end of the molecule, with a PEG chain between. According
to a systematic study conducted by Ostuni et al.,126 a molecule that contains

≥ 3 ethylene glycol units effectively resists the adsorption of proteins. PEG or PEGcontaining materials have been widely used as slab gel matrix, capillary electrophoresis
coating, capillary gel electrophoresis matrix, and artificial organ coating.127-130 A unique
feature of PEG is that it does not denature proteins, even during precipitation at high
concentration, which is in sharp contrast to other organic solvents (e.g., acetonitrile)
which tend to denature proteins.131
With the use of PEGDA as a crosslinker, a strong cation-exchange (SCX)
polymer monolith was recently introduced for capillary liquid chromatography of
peptides, as described in Chapter 3.101 Using simple one-step copolymerization of AMPS
and PEGDA, the resulting monolith provided extremely narrow peaks and high peak
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capacity. Although not completely understood, the extraordinary chromatographic
performance is believed to be related to the use of the biocompatible crosslinker PEGDA.

1.3.3

Application of Polymer Monoliths
Due to ease of preparation and enhanced mass transfer, polymer monoliths have

found numerous applications in a variety of fields related to the analysis of biological
samples. These include preconcentration and solid-phase extraction,132 enzyme bioreactor
for protein digestion,106 capillary electrochromatography,133-136 chip
electrochromatography,90 and liquid chromatography (both in analytical and capillary
formats).137-139 A detailed description of all of these applications is beyond the scope of
this dissertation. Instead, applications of polymer monoliths to the analysis of biological
analytes in capillary liquid chromatography will be briefly reviewed.

Acrylamide-based monoliths. The first monolithic capillary column was based
on polyacrylamide.140 A small amount of butyl acrylate was copolymerized with a large
amount of methylenebisacrylamide in a 300 µm i.d. capillary via typical APS-TEMED
redox initiation. The resulting monolith was successfully used for hydrophobic
interaction chromatography of model proteins. One main problem of this early approach
was the compressibility of the monolith. For example, an initial length of 60 cm was
compressed to 7 cm upon applying pressure. To improve the mechanical strength of the
polyacrylamide-based monolith, two modifications were made. One was to treat the inner
wall of the capillary with 3-(trimethoxysilyl)propyl methacrylate (TPM) to fix a pendant
double bond on the inner wall. The other was to use a new crosslinker, piperazine
diacrylamide, to replace the conventional methylenebisacrylamide crosslinker. Using
these improved methods, stable polyacrylamide monoliths (no compression during usage)
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were prepared in both 320 µm and 10 and 25 µm i.d. capillaries. The monoliths were
demonstrated for fast weak cation-exchange chromatography of model basic
proteins.141,142

Acrylate or methacrylate-based monoliths. It is somewhat surprising that
development of capillary acrylate or methacrylate-based monoliths for protein analysis
lagged far behind that of acrylamide-based monoliths. In 2004, a polymer monolith
synthesized from the copolymerization of BMA and EDMA using photoinitiation was
reported.97 The monolith was prepared in a 200 µm i.d. UV transparent fused silica
capillary and used for fast RP LC of proteins. As a result of the through-pore diameter of
2.24 µm, the monolith had extremely low flow resistance. Baseline separation of
ribonuclease A, cytochrome c, myoglobin and ovalbumin was achieved in 40 s using a
flow rate of 100 µL/min and an optimized steep gradient.
Lee’s group was the first to prepare acrylate-based monolithic capillary columns for
LC of peptides and proteins.99,101 The main contribution of this work was the
development of a novel PEGDA crosslinker, which effectively resists adsorption of
proteins and peptides. As a result, the contribution of the crosslinker to monolith
hydrophobicity was minimized. The PEGDA crosslinker is particularly useful for
separation techniques that can analyze biomolecules in their native states (e.g., SEC, IE,
and affinity chromatography). Detailed descriptions of these studies will be provided in
Chapters 2-4.
Affinity capillary LC of glycoproteins and glycans using polymethacrylate
monoliths was recently reported by El Rassi’s group.143-145 Both neutral poly(GMA) and
cationic poly(GMA-co-METC) monoliths were synthesized in 100 µm i.d. fused silica
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capillaries using thermal initiation. Two lectins including concanavalin and wheat germ
agglutinin were used to selectively trap very low concentration (~10-8 M) glycoproteins
and glycans that contained sugar sequences recognized by the lectins. By synthesizing
and coupling another polyacrylate monolith (based on pentaerythritol diacrylate
monostearate) that could be used for RP LC, a 2-D separation scheme was
demonstrated.144

Norbornene-based monoliths. Buchmeiser’s group developed norbornene-based
monoliths via the ROMP approach.88,89,110,146 A decrease in i.d. from analytical (3 mm)89
to capillary (200 µm)146 increased the resolution of oligodeoxynucleotides by two times,
presumably due to better temperature control in the capillary during the preparation of the
monolith. A variety of biomolecules, such as oligodeoxynucleotides, double-stranded
DNA fragments and proteins, were separated using monolithic capillary columns in the
RP LC mode.146

Styrene-based monoliths. The first demonstration of preparing a styrene-based
monolith in a capillary was reported in 1998.147 The capillary had an i.d. of 150 µm with
a pulled 5-10 µm needle tip at one end, which served both as a separation unit and an
electrospray device. The polystyrene monolith was formed inside the pulled capillary by
thermal initiation at 65 ºC and used for separation and electrospray ionization of peptides
and proteins. Equal or better chromatographic performance (i.e., resolution and signal
strength) was obtained using the monolithic pulled capillary compared to a similar
capillary packed with either C18 silica particles or polystyrene beads. Due to their
hydrophobic nature, polystyrene monoliths are exclusively used in the RP
chromatography mode.

34

Using a similar approach, several other groups have prepared polystyrene monoliths
in the capillary format for RPLC of peptides, proteins and nucleic acids.123,124,147-157 The
preparation of polystyrene monoliths typically involved toluene and decanol as porogens.
Huber’s group improved polystyrene monoliths significantly by using THF and decanol
as porogens.124 They claimed that a large number of mesopores were formed because
THF is a worse solvent than toluene. As a result, mass transfer resistance became much
smaller. In fact, they demonstrated extremely efficient separation of proteins and peptides
using their polystyrene monolithic columns. The peak width at half height for most
proteins was <10 s.148 Another noteworthy development of the polystyrene monolith was
reported by Karger’s group.151 By preparing monoliths in 20 µm i.d. capillaries, the
detection sensitivity was improved by 20 fold over 75 µm i.d. columns, enabling the
detection of 10-40 fmol peptides. Excellent efficiency (100,000 plates/m) was obtained
for RPLC of peptides. Attempts were also made to increase the hydrophobicity of the
bare polystyrene monolith.150 After the polystyrene monolith was prepared, an additional
derivatization step, which involved Friedel-Crafts alkylation with chlorooctadecane in the
presence of aluminum chloride as a catalyst, was performed to introduce C18 chemistry
onto the monolith. However, as compared to the original polystyrene monolith, only
marginal improvement in retention and peak shapes was obtained.

1.4 Significance and Content of this Dissertation
1.4.1

Significance
Liquid chromatography of proteins can be performed in two different ways: under

denaturing conditions and under native conditions. The RP mode is in the first category
while other modes of chromatography, such as ion exchange, affinity, size exclusion, and
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hydrophobic interaction, belong to the second category. As reviewed in Section 1.2,
RPLC is the most popular mode for proteomics studies. This is reasonable because RPLC
can be directly coupled with MS, the most powerful detector for proteomics research at
the present. In addition, RPLC is a well developed technique that has superior selectivity,
efficiency, and resolution compared to other modes of chromatography. The rapid
development of polystyrene monoliths for RP capillary liquid chromatography (CLC) of
biomolecules (Section 1.3.3) confirmed the usefulness of this mode. However, other
modes of chromatography are equally important for proteomics studies (see 2-D LC for
proteomics in Section 1.2.2) because they are complementary to the RP mode. At present,
polymer monoliths for these chromatographic modes are less developed.
For analysis of proteins in their native states, hydrophobic interaction is
detrimental to most separations except for hydrophobic interaction chromatography. The
PEGDA crosslinker has been proven to effectively resist nonspecific hydrophobic
interactions of proteins (see Section 1.3.2). As a result, it contributes negligible
hydrophobicity if used as a crosslinker to synthesize a monolith. It was another aim of
this dissertation to investigate the use of PEGDA as a biocompatible crosslinker to
prepare polymer monoliths for the analysis of peptides and proteins in their native states.
Because PEGDA contributes insignificant hydrophobicity to the polymer monolith
backbone, I hoped that highly efficient monoliths could be prepared using this novel
crosslinker. With the development of highly efficient, high resolution capillary LC
methods based on polymer monoliths, enhanced resolving power of 2-D LC should be
realized, which would encourage more applications of LC in proteomics research.
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1.4.2

Overview of this Dissertation
Chapter 2 reports the design, preparation and evaluation of an inert polymer

monolith for use in SEC. PEGMEA was used as monomer and PEGDA as crosslinker. A
macroscopically uniform monolith with low flow resistance was obtained using methanol
and ethyl ether as porogens via photoinitiation. The optimized monolith was successfully
applied to SEC of peptides. By replacing PEGMEA with ionizable monomers, monoliths
with IE functionalities could be obtained. Chapters 3 and 4 report the synthesis of SCX
monoliths for resolution of peptides and proteins. In Chapter 3, AMPS was used as the
functional monomer. A ternary porogen, water/methanol/ethyl ether, was found suitable
to prepare the poly(AMPS) monolith. Due to the use of the biocompatible PEGDA
crosslinker, extremely sharp peaks were obtained for LC of both synthetic and natural
peptides including a tryptic digest. A peak capacity of 179 was obtained using a shallow
salt elution gradient. Although very successful, the main drawback of the poly(AMPS)
monolith was its relatively strong hydrophobicity, i.e., 40% acetonitrile was required to
suppress hydrophobic interactions for hydrophobic peptides. Chapter 4 deals with
improvements in hydrophilicity by using two other commercially available sulfonic acidcontaining monomers to prepare SCX monoliths: sulfoethyl methacrylate (SEMA) and
vinyl sulfonic acid (VS). The hydrophobicities of the resulting monoliths were
systematically evaluated. Results show that the poly(VS) monolith was the least
hydrophobic among the three SCX monoliths studied. The poly(VS) monolith was
applied to the separation of various proteins including lipoproteins using capillary LC.
Five subclasses of high density lipoproteins were separated under a linear salt gradient.
Chapter 5 outlines future proposed research using the PEGDA crosslinker.
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CHAPTER 2 PREPARATION AND EVALUATION OF
POLY(POLYETHYLENE GLYCOL METHYL ETHER ACRYLATE-COPOLYETHYLENE GLYCOL DIACRYLATE) MONOLITH FOR PROTEIN
ANALYSIS*

2.1 Introduction
Minimal interaction of support matrix and analytes is desirable for separations
such as gel electrophoresis and size exclusion chromatography of proteins. Proteins are
well known to exhibit hydrophobic and/or ionic interactions with a variety of surfaces.
Therefore, an inert material, which can significantly reduce or eliminate adsorption of
proteins, would be very useful.
Known materials that resist protein adsorption include polysaccharide and
polyacrylamide polymers; these enjoy wide application in gel electrophoresis and size
exclusion separation of proteins.1 An efficient method to address adsorption problems in
capillary electrophoresis is to coat the capillary surface with such polymers.2,3 In addition
to polysaccharide and polyacrylamide, other neutral hydrophilic polymers have been
investigated and found useful in capillary electrophoresis, such as polyvinyl alcohol,4
polyethylene oxide,5,6 polyvinylpyrrolidinone7 and a copolymer of polyethylene glycol
and polypropylene glycol.8 All of these polymers are neutral and hydrophilic. A
systematic study of protein adsorption on a variety of surface structures resulted in the
conclusion that materials are protein compatible if they are neutral, hydrophilic, proton
acceptors and not proton donors.9-11
*

This chapter is reproduced with permission from J. Chromatogr. A 2005, 1079, 382-391. Copyright 2005 Elsevier B. V.
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Other materials used in gel electrophoresis reported in 1992 by Zewert and
Harrington are polyhydroxy methacrylate, polyhydroxy acrylate, polyethylene glycol
methacrylate and polyethylene glycol acrylate.12,13 To avoid the toxicities of acrylamide
and bisacrylamide, and the difficulties associated with polyacrylamide gel electrophoresis
of very hydrophobic proteins, such as bovine serum albumin or zein, polyethylene glycol
methacrylate 200 in hydroorganic solvents was evaluated. Although there was no direct
evidence to show the inertness of this material, successful electrophoresis of proteins
demonstrated the protein compatibility of such polymers.
The inert polymers mentioned above are polymer gels that are soft in nature.
These polymers can only be used in their swollen states because such polymers lose their
permeabilities upon drying. Attempts have been made to prepare rigid beads with
permanent porous structures from such polymers. Among these hydrophilic polymers,
polyacrylamide is the only one that could form rigid beads by inverse suspension
techniques using a high content of bisacrylamide as a crosslinker.14 The use of a higher
level of crosslinker accounted for the formation of rigid beads instead of soft particles.
As introduced in Chapter 1, monolithic materials offer an alternative to columns
packed with small particles or beads. Attempts have been directed towards the synthesis
of polyacrylamide monoliths. The first demonstration of preparing a poly(acrylic acid-comethylene bisacrylamide) monolith was performed in 1989 by Hjertén’s group.15
However, the monolith was soft. Several years later, a rigid poly(acrylamide-cobisacrylamide) monolith was reported in 1997 by Svec’s group.16 Several variables were
studied to prepare a flow-through monolith with a mean pore diameter of ~ 1 µm. The
porogens used for preparing the acrylamide-co-bisacrylamide monolith were dimethyl
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sulfoxide and a long chain alcohol, such as heptanol or dodecanol. The concentration of
initiator was also investigated to adjust the medium pore diameter of the monolith; a
lower concentration of initiator increased the permeability of the resulting monolith as
expected. Unfortunately, thermally initiated polymerization was used to prepare the
monolith. As a result, 24 h was required to complete the polymerization at 1% initiator
concentration.
In this Chapter, a protein compatible poly(polyethylene glycol methyl ether
acrylate co-polyethylene glycol diacrylate) monolith (PEGMEA-co-PEGDA) was
prepared by photo-initiated polymerization. Physical properties, such as pressure drop
and swelling or shrinking in organic solvents, were characterized first, and then inertness
in LC was evaluated by using a series of both acidic and basic model proteins under a
variety of buffer conditions.

2.2 Experimental
2.2.1

Chemicals
Anhydrous methanol, anhydrous ethyl ether and ACS reagent hexanes were

purchased from Mallinckrodt Chemicals (Phillipsburg, NJ), Fisher Scientific (Fair Lawn,
NJ) and EMD Chemicals (Gibbstown, NJ), respectively. HPLC grade toluene and THF
were from Mallinckrodt Chemicals, and Curtin Matheson Scientific (Houston, TX),
respectively. All other solvents (cyclohexanol, dodecanol and dimethyl sulfoxide) were
of analytical grade or better. Phosphate buffer solutions were prepared with deionized
water from a Millipore water purifier (Molsheim, France) and filtered through a 0.22 µm
filter. Thiourea (99.9%), 2,2-dimethoxy-2-phenylacetophenone (99%), 3(trimethoxysilyl)propyl methacrylate (98%), ethylene glycol dimethacrylate (EDMA,
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98%), polyethylene glycol methyl ether acrylate (PEGMEA, average molecular weight,
Mn, ~454), and polyethylene glycol diacrylate (PEGDA, Mn ~575 and ~258) were
supplied by Sigma-Aldrich (Milwaukee, WI) and used without further purification.
Proteins {pepsin from porcine stomach mucosa, bovine serum albumin (>99%),
myoglobin from horse skeleton muscle, α-chymotrypsinogen A from bovine pancreas,
lysozyme from turkey egg white, and bovine serum albumin fluorescein isothiocyanate
conjugate (FITC-BSA)} and peptides {neurotensin, angiotensin II fragment 3-8 and
leucine enkephalin} were also obtained from Sigma-Aldrich.

2.2.2

Capillary Liquid Chromatography
UV transparent fused silica capillary tubing with 75 µm i.d. and 365 µm o.d. was

supplied by Polymicro Technologies (Phoenix, AZ). Capillary LC experiments were
performed with an ISCO Model 100 DM syringe pump (Lincoln, NE), 60 nL Valco
internal sample loop (Houston, TX), a Linear Scientific UVis 203 detector (Reno, NV)
and a Thermo Separations PC 1000 V3.0 software work station (Fremont, CA) for data
collection and treatment. The PC 1000 provided retention times, peak heights, peak areas,
asymmetry factors and column plate counts. On-column UV detection was performed at
214 nm. Chromatograms were transferred to an ASCII file and redrawn using Microsoft
Excel (Redmond, WA).

2.2.3

Preparation of Polymer Monoliths
Before filling the UV transparent capillary with monomer mixture, the capillary

inner surface was treated with 3-(trimethoxysilyl)propyl methacrylate (commercial
identification number Z-6030) to ensure covalent bonding of the monolith to the capillary
wall.3,17 Briefly, the capillary was rinsed sequentially with acetone, water, 0.2 M NaOH,
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water, 0.2 M HCl, water and acetone using a syringe pump for 30 min each at a flow rate
of 5 µL/min. The washed capillary was then dried in an oven at 120 ºC for 1 h, filled with
a 30% Z-6030 acetone solution, sealed with a rubber septum and placed in the dark for 24
h. The vinylized capillary was then washed with acetone at a flow rate of 5 µL/min for 10
min, dried using a stream of nitrogen for 3 h, and sealed with a rubber septum until used.
Four monolith recipes shown in Table 2.1 were designed to test protein
compatibility, and the monoliths were prepared as follows. The monomer mixture was
prepared in a 1 dram (4 mL) glass vial by admixing in sequence the initiator, monomer,
crosslinker and porogens, and ultrasonicating for 5 min before use. Because of the low
viscosity of the monomer solution, the introduction of monomer solution into the UV
transparent capillary was facilitated by capillary surface tension. The capillary was then
placed under a Dymax 5000AS UV curing lamp (Torrington, CT) for 10 min. For
measurement of polymerization conversion (vide infra), a series of irradiation times were
used. The UV curing lamp can produce an irradiation intensity of 200 mW/cm2 in the
wavelength range of 320 ~ 390 nm.

2.2.4

Laser Induced Fluorescence Imaging of FITC-BSA
Laser induced fluorescence (LIF) imaging of FITC-BSA in a series of capillary

columns was performed in a device described elsewhere.18 Briefly, the 488 nm line from
an Ar ion laser was used to excite the sample, and the fluorescence was imaged using a
Nikon Coolpix 995 digital camera (Tokyo, Japan).

2.2.5

Pressure Drop Measurements
Pressure drop measurements were performed using a Fisons Phoenix 20 CU

HPLC pump (Milano, Italy) in the constant flow mode. Methanol and THF were pumped
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Table 2.1. Composition of reagent solution for various monoliths used in this study.
Recipes for monoliths 1 and 4 reagents were optimized. Units are in g.
No.

DMPA

PEGMEA

EDMA

PEGDA

Ethyl ether

Other

#1

0.008

0.32

0.48

-

-

0.008

-

0.8

-

1.20

0.38 cyclohexanol +
0.58 dodecanol +
0.24 hexanes
-

#2
#3

0.006

-

-

0.6

1.40

-

#4

0.006

0.15

-

0.45

1.10

0.30 methanol
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through the monolithic column at flow rates of 4, 6, 8 and 10 µL/min, respectively, and
the pressure drop for water was measured at 4 µL/min. After stabilizing, the pump
pressure was recorded.

2.2.6

Polymerization Conversion Evaluation and Scanning Electron Microscopy
A bulk solution of 10 g optimized monomer mixture (monolith #4, Table 2.1) was

prepared based on the procedure outlined in Section 2.2.3. An aliquot of 0.3 g of the
monomer mixture was dispensed into a series of 1 dram (4 mL) glass vials and irradiated
under the UV lamp for 10 s, 20 s, 30 s, 1 min, 2 min, 5 min, 10 min, and 30 min,
respectively. The bulk monolith was carefully removed by breaking the glass vial, sliced
into sections, Soxhlet extracted with methanol overnight and placed in a vacuum oven at
60 ºC overnight. The dried monolith material was weighed and compared with the
combined weight of the monomer and crosslinker to obtain the conversion of monomer to
polymer.
One of the dry monoliths (i.e., with 10 min irradiation time) was also used to
obtain the SEM images. The monolith was sputtered with ~20 nm gold, and SEM images
were taken using an FEI Philips XL30 ESEM FEG (Hillsboro, OR).

2.2.7

Inverse Size Exclusion Chromatography (ISEC)
The same liquid chromatographic system as described in Section 2.2.2 was used

to run the ISEC. The mobile phase was THF and detection was at 254 nm. Narrow
distribution polystyrene standards with molecular masses of 201, 2 460, 6 400, 13 200, 19
300, 44 100, 75 700, 151 500, 223 200, 560 900, 1 045 000, 1 571 000 and 1 877 000
were purchased from Scientific Polymer Products (Ontario, NY). A solution of 1 mg/mL
polystyrene and toluene each in THF were chromatographed.
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2.2.8

Protein Recovery Determination
A monolithic column with a total length of 80 cm and effective length of 60 cm

was prepared with one detection window at 19 cm and the other at 60 cm from the
column inlet. The detection window at 19 cm was created by carefully introducing an air
bubble during introduction of the monomer solution. A mixture of protein and thiourea
(an internal standard to calibrate any detection window response variation due to different
background absorbances of the two detection windows) was injected into the monolithic
column. Protein recovery was calculated by comparison of the calibrated protein peak
area from the second detection window with that from the first one. The calibrated peak
area of a protein was obtained by dividing the protein peak area by that of thiourea from
the same detection window.

2.3 Results and Discussion
2.3.1

Crosslinker Influence on Inertness of the Monolith
Initially, EDMA was chosen as a crosslinker to prepare the PEGMEA monolith

because EDMA has been widely used in the preparation of rigid porous polymer
monoliths, such as butyl methacrylate, glycidyl methacrylate and 2-hydroxyethyl
methacrylate.19 However, the resultant monolith (monolith #1, Table 2.1) exhibited
strong adsorption of FITC-BSA as shown in the LIF images (see Figure 2.1, A panels).
To investigate the cause of adsorption of BSA in the poly(PEGMEA-co-EDMA)
monolith, monolith #2 composed of pure EDMA was prepared with ethyl ether as
porogen. Not surprisingly, the EDMA monolith had a strong fluorescence residue after
introducing FTIC-BSA and flushing with 0.1 M phosphate buffer (pH 7.0) containing 0.5
M NaCl buffer (Figure 2.1, B panels). Because polyethylene glycol is known not to
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A

B

C

D

Figure 2.1. LIF images of the monolith before, during and after loading of FITC-BSA.
Procedures: the LIF image was first recorded before loading of FITC-BSA for which a
dark background was obtained for all monoliths; the monolithic column was loaded with
0.01 mg/mL FITC-BSA and the fluorescence image was taken; the monolithic column
was then flushed with 100 mM (pH 7.0) phosphate buffer containing 0.5 M NaCl for 5
min under a linear flow velocity of ~4 mm/s, and the LIF image was obtained again. (A)
PEGMEA/EDMA monolith; (B) EDMA monolith; (C) PEGDA Mn ~258 monolith; (D)
PEGMEA/PEGDA monolith; the monomer recipes for all of the monoliths are listed in
Table 2.1.
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adsorb proteins, PEGDA was chosen as a crosslinker for the preparation of the PEGMEA
monolith. Results of the use of PEGDA with Mn ~575 as crosslinker showed that the
PEGMEA/PEGDA monolith did resist the adsorption of proteins (data not shown).
Unfortunately, the resultant monolith was compressible upon application of >1000 psi
buffer even though 75% crosslinker was used in the monomer recipe. This indicates that
the PEGMEA monolith with long-chain PEGDA crosslinker yielded a soft monolith.
However, replacement of PEGDA Mn ~575 with PEGDA Mn ~258 dramatically
improved the rigidity of the monolith. From the fluorescence images (Figure 2.1, C
panels) of this new polymer monolith #3, no obvious adsorption of FITC-BSA was
observed. Therefore, PEGDA Mn ~258 was finally selected as the crosslinker to prepare
the PEGMEA/PEGDA monolith (monolith #4, Table 2.1). A fluorescence test of the
optimized PEGMEA/PEGDA monolith also showed no adsorption of FITC-BSA (see
Figure 2.1, D panels).

2.3.2

Optimization of Porogen Composition
To be useful in flow-through applications, the monolith must have low flow

resistance. Furthermore, for chromatographic use, a homogeneous monolith is critical for
achieving high efficiency. Here, homogeneity refers to the uniformity of monolithic bed
along both radial and axial directions. Because polymer monoliths are made of tiny
globules which are connected together to form the continuous rod, they are
microscopically heterogeneous. Thus, homogeneity in this dissertation refers to the
uniformity of monolithic bed macroscopically. If the monolith is free of voids or cracks
and its color is uniform (some monoliths had dark and light spots along the axial
direction of the column, indicating that they were inhomogeneous) under examination of
a microscope, this monolith is referred to as homogeneous, and vice versa. Therefore,
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optimization was performed to prepare a homogeneous monolith with flow resistance as
low as possible.
Five factors can be adjusted to change the pressure drop of the polymer monolith
(see Section 1.3.2.3 for a detailed discussion about control of the porosity of the polymer
monoliths). For the preparation of the PEGMEA/PEGDA monolith, when ethyl ether was
used as porogen, the crosslinker had to be greater than 70% to make a rigid monolith. As
a result, 75% PEGDA (crosslinker) and 25% PEGMEA (monomer) were used throughout
the optimization of the monolith. The total monomer to porogen ratio was kept constant
at 3:7 and the initiator concentration was 1% of the monomers. A variety of solvents were
evaluated to prepare the PEGMEA/PEGDA monolith. First, 30% PEGMEA or PEGDA
solutions (containing 1% DMPA as photoinitiator) in ethyl ether, hexanes, cyclohexanol,
dodecanol, dimethyl sufoxide, methanol, toluene or THF were prepared and placed under
the UV lamp to find the best porogens for the PEGMEA/PEGDA monolith. PEGMEA
and PEGDA both dissolved well in all solvents except hexanes. For PEGMEA,
dodecanol formed a white solid material, and dimethyl sulfoxide resulted in a transparent
soft gel. All other solvents formed a dense liquid after 10 min UV irradiation. For
PEGDA, dimethyl sulfoxide and THF resulted in transparent solid materials, which
indicated the formation of an extremely small pore structure. All other solvents yielded a
white solid, except toluene which formed a yellow rigid solid.
A 2 cm long monolith prepared in a UV transparent capillary was used to test the
pressure drop of the monolith composed of only PEGDA. Ethyl ether and methanol
porogens yielded a porous monolith, whereas all others would not allow flow at 4500 psi
methanol. This is also in contrast to other reported monoliths for which a long-chain

58

alcohol, such as cyclohexanol or dodecanol, was used to prepare a porous monolith.16,17,20
Therefore, methanol and ethyl ether were selected as porogens to optimize the
preparation of the PEGMEA/PEGDA monolith. Since both PEGMEA and PEGDA do
not dissolve in hexanes, and both dissolve in mixtures of hexanes and methanol or ethyl
ether, hexanes was selected as a macroporogen for the monolith. Thus, the final porogens
selected were methanol, ethyl ether and hexanes.
Three porogen mixtures, i.e., methanol/hexanes, ethyl ether/hexanes and
methanol/ethyl ether, were optimized for the desired homogeneity and flow resistance of
the monolith. The pressure drop of the monolith was found to be insensitive to the ratio
of methanol and hexanes or ethyl ether and hexanes. Fortunately, the flow resistance of
the monolith was found to be strongly dependent on the ratio of methanol and ethyl ether
(see Figure 2.2, panel A). For the optimized recipe (monolith #4), i.e, 7.5% PEGMEA,
22.5% PEGDA, 15% methanol and 55% ethyl ether, the pressure drop was 21
psi/(µL/min·cm) when methanol was used as pumping liquid in a 75 µm i.d. monolithic
capillary. For a 20 cm × 75 µm i.d. capillary, this corresponds to a linear flow velocity of
3.78 mm/s of methanol at a pressure of 420 psi.
The SEM images of the optimized PEGMEA/PEGDA monolith are shown in
Figure 2.3. From the images, a rough estimation of 0.2~0.3 µm diameter globule size
could be made. If these globules were tightly packed as in a packed column, pressure
drop would be tremendously high. Thus, the low flow resistance (21 psi/(µL/min·cm))
would be contributed from large through-pores or large porosity of the monolith. It may
also be a result of a high degree of connectivity of the through-pores, which has been
shown to be an important factor affecting the permeability of a monolith in theoretical
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Figure 2.2. Flow resistance of the PEGMEA/PEGDA monolith. (A) Pressure drop
dependence of the monolith on the percent of ethyl ether; inset is the magnification of the
section for ethyl ether of 60 ~ 100%; (B) linear pressure dependence of the optimized
PEGMEA/PEGDA monolith on the flow rates of water, THF and methanol.
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A

B

Figure 2.3. SEM images of the optimized PEGMEA/PEGDA monolith. (A) 5000
magnification; (B) 20000 magnification.

61

studies.21,22 The shrinking of the monolith in methanol (vide infra), could also lead to low
flow resistance.

2.3.3

Kinetics of Polymerization of PEGMEA/PEGDA
Both thermal and UV-initiated polymerization can be used to prepare polymer

monoliths. Typically, thermally initiated polymerization uses AIBN as initiator, and
polymerization proceeds slowly, normally taking 24 h.16,17 In contrast, photo-initiated
polymerization can be finished in minutes.20 The kinetics of polymerization of
PEGMEA/PEGDA are shown in Figure 2.4. Over 90% of the monomer was converted
into polymer in 2 min, and complete conversion of the monomer was finished in ~10
min. The high irradiation intensity (200 mW/cm2) used in my experiments, which is ~10
fold greater than a previously reported UV curing system,20 contributed to the fast
polymerization of the monomer solution.

2.3.4

Physical Properties of the PEGMEA/PEGDA Monolith
A quantitative index, the swelling propensity (SP), was defined by Nevejans and

Verzele23 to characterize the swelling and shrinking properties of a packed bed:

SP =

p ( solvent ) − p ( H 2 O)
p( H 2 O)

where p takes into account the viscosities of the solvent, and is defined as the ratio of
pressure over solvent viscosity. By definition, SP = 0 if no swelling or shrinking occurs,

SP > 0 if there is swelling, and SP < 0 if the packed bed shrinks. From Figure 2.2B, the
SP values for methanol and THF were calculated to be -0.44 and -0.08, respectively,
assuming viscosities for water, methanol and THF of 1.025, 0.59 and 0.55 cP,
respectively, at room temperature (data from the online CRC Handbook at 25 oC). This
indicates that no significant shrinking or swelling of the PEGDA/PEGMEA monolith in
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Figure 2.4. Rate of conversion of monomers to polymer. For experimental conditions, see
Section 2.2.6.
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THF was observed. Since THF can dissolve most hydrophobic polymers, the stability of
the monolith in THF indicates that the monolith is relatively non-hydrophobic. However,
shrinking of the monolith did occur in methanol, which unexpectedly had a positive
effect because it improved the column permeability while maintaining a rigid structure.
As shown in Figure 2.2B when 2600 psi THF was applied to the monolithic column (4
cm × 75 µm i.d.), no change in pressure drop was observed. This indicates high stability
of the monolith, which is a result of the high concentration of crosslinker used in the
monomer recipe.

2.3.5

Chromatographic Evaluation of the Monolith
Proteins were carefully selected to investigate the possibility of hydrophobic or

ionic interaction with the monolithic material. Acidic (pepsin), basic (lysozyme) and
hydrophobic (BSA) proteins were included. Several peptides with different molecular
masses were also used to explore the elution mechanism of the monolithic column. Table
2.2 lists the molecular masses and pIs of the proteins and peptides used in this study.
Phosphate buffers, (a) pH 7.0 with concentrations of 10, 20, 50, 100, 200, and
500 mM; (b) 10 mM concentration with pH values of 2.0, 4.0, 6.0, 8.0, 10.0, and 12.0;
and (c) 100 mM concentration (pH 7.0) with additives of 0.5 M Na2SO4, 0.5 M NaCl,
10% ethylene glycol or 10% acetonitrile, were used to elute the proteins. Buffers (a) and
(c) were used to explore the possible hydrophobic interaction of the proteins with the
monolith, and buffer (b) was used to investigate the possibility of any ionic interactions.
In all cases, the proteins eluted earlier than thiourea. This indicates an SEC elution mode.
When buffer (a) was used, splitting of all of the protein peaks was observed when
the buffer concentration was increased to 500 mM. However, the elution times were kept
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Table 2.2. Proteins and peptides used in this study.
Analyte

Molecular mass

pI

bovine serum albumina

68 000

4.7

pepsina

34 000

<1

α-chymotrypsinogen Aa

24 000

8.8

myoglobina

17 500

7.1

lysozymea

14 000

11.0

neurotensinb

1 672.9

9.5

angiotensin II fragment 3-8b 774.9

7.8

Leucine enkephalinb

5.9

a

555.6

The molecular mass and isoelectric point (pI) of proteins were obtained from “Schmidt,

Jr., D. E.; Giese, R. W.; Conron, D.; Karger, B. L. Anal. Chem. 1980, 52, 177-182.”
b

The molecular mass of peptides were read from the label of the chemicals provided by

Sigma-Aldrich, and the pI values were obtained from EMBL Heidelberg European
Molecular Biology Laboratory program http://www.embl-heidelberg.de/cgi/piwrapper.pl).
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nearly constant for the proteins investigated within experimental error (except for the 500
mM buffer because two retention times were obtained due to peak splitting). Buffer (c),
0.5 M Na2SO4 in 100 mM (pH 7.0), also caused splitting of the protein peaks. This
indicates possible hydrophobic interaction of the proteins with the monolith. However,
10% ethylene glycol or even 10% acetonitrile in buffer (c) (in which αchymotrypsinogen A forms a precipitate in the buffer with acetonitrile as an additive)
provided elution of proteins in a similar manner as 0.5 M NaCl additive. Not only were
protein profiles similar to each other when buffer (c) was used, but the elution times were
also close to each other within experimental error. This strongly suggests that
hydrophobic interactions, if any, would not be very significant.
The pH of buffer (b) was found to strongly affect the protein peak profiles. At pH
2.0, all proteins showed some degree of tailing, and α-chymotrypsinogen A and
lysozyme exhibited peak splitting. Above pH 4.0, the symmetry of the protein peaks
improved, except that lysozyme split into two peaks at all pH values. This indicates a
possible ionic interaction between lysozyme and the monolith. However, as shown above,
this weak ionic interaction disappeared when buffer (c) with 0.5 M NaCl additive (weak
buffer ionic strength) was used.
In summary, good peak symmetries for all of the proteins were obtained with the
use of buffer (c) with 0.5 M NaCl additive, i.e, 100 mM phosphate (pH 7.0) buffer
containing 0.5 M NaCl, a condition often employed in high performance SEC of proteins.
This indicates that the PEGMEA/PEGDA monolith had insignificant hydrophobic or
ionic interactions with the proteins. It should be mentioned that all of the experiments
described above employed high mobile phase flow rate (~1.10 mm/s) so that proteins
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eluted within ~3 min from a ~20 cm monolithic column. Such a flow rate facilitates the
screening of buffers at the expense of skewing protein peaks. If a lower flow rate was
used, improvement in peak symmetry could be achieved.
Figure 2.5A shows a chromatogram of a mixture of proteins and thiourea using
low mobile phase flow rate. No separation between these proteins was observed.
Injections of each protein in the same column under the same chromatographic conditions
revealed that all of the five proteins with different molecular masses and pIs had almost
the same elution time (Figures not shown). In contrast, for the chromatography of three
peptides, a moderate separation was achieved, although they were not baseline resolved
(see Figure 2.5, panel B). A mixture of α-chymotrypsinogen A, the three peptides and
thiourea was thus injected into the column, and the chromatogram is shown in Figure 2.5
panel C. Although the elution time for proteins was a little earlier than neurotensin
(compare Figures 2.5 panels A and B), coelution of α-chymotrypsinogen A and
neurotensin was observed. Since I aim at developing an inert monolith with pressure drop
as low as possible while keeping it homogeneous macroscopically, no further
optimization of pore size distribution was attempted for SEC of proteins.
It should be mentioned that the protein peak shown in Figure 2.5A was a
coelution profile of five proteins, and thus it was relatively broad. Chromatography of
each of the five proteins revealed column efficiencies of 6 000 ~ 8 000 plates/m and
asymmetric factors of 1.3 ~ 1.5. For peptides and thiourea, elution of each of them
separately under otherwise the same chromatographic conditions resulted in column
efficiencies of 9 000 ~ 20 000 plates/m and asymmetric factors of <1.1. This roughly
follows the trend of SEC. In the SEC of proteins, significantly lower plate counts for
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Figure 2.5. Chromatograms of mixtures of several peptides, proteins and thiourea under
isocratic elution. Conditions: 60 cm × 75 µm i.d. PEGMEA/PEGDA monolithic column;
100 mM phosphate buffer (pH 7.0) containing 0.5 M NaCl operated under 600 psi
constant pressure; online UV detection at 214 nm; 0.15 mg/mL of thiourea, 0.8 mg/mL of
each protein, and 0.5 mg/mL of each peptide; (A) mixture of bovine serum albumin,
pepsin, α-chymotrypsinogen A, myoglobin, lysozyme and thiourea; (B) mixture of
neurotensin, angiotensin II fragment 3-8, leucine enkephalin and thiourea (in elution
order); (C) mixture of α-chymotrypsinogen A, neurotensin, angiotensin II fragment 3-8,
leucine enkephalin and thiourea; for physical properties of the proteins and peptides, see
Table 2.2.
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proteins than for small molecules have been observed due to the lower diffusion
coefficients of the macromolecules. The typical plate counts in modern conventional SEC
(column dimensions of 250 mm × 4.6 mm i.d.) ranged from 8,000 plates/m for proteins
(i.e., amylase) to 34,000 plates/m for small molecules (i.e., glycyl tyrosine).24 For
example, a plate count in SEC for α-chymotrypsinogen A was estimated to be ~5,600
plates/m based on a previously published chromatogram.25 Thus, the plate counts
achieved for proteins in this study with the use of the polymer monolith are acceptable.
Furthermore, a plate count of 2240 ~ 6400 plates/m was reported in monolithic SEC of
polystyrenes in THF.26

2.3.6

ISEC Characterization of the PEGMEA/PEGDA Monolith
To clarify the separations of proteins and peptides as shown in Figure 2.5, the

porosity and pore size distribution of the PEGMEA/PEGDA monolith were investigated
by ISEC. ISEC was initially used to characterize the structure of a packed bed with
known probe compounds, e.g., polystyrene standards with narrow molecular mass
distribution.27 Guiochon and coworkers were among the first to use ISEC to characterize
the porous structure of silica monoliths.28 They defined several terms to describe the
structure of a monolithic bed, such as total porosity ε t , external porosity ε e and internal
porosity ε i . Based on the ISEC plot, a pore size distribution of a monolith could also be
derived assuming a simple correlation of M w = 2.25(10d )1.7 , where M w is the molecular
mass of the polystyrene standard, and d is the diameter of the polystyrene standard in nm.
Following the method of Gouichon et al.,28 I obtained the ISEC plot of the
PEGMEA/PEGDA monolith which is shown in Figure 2.6A.
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Figure 2.6. ISEC plot (A) and accumulated pore size distribution (B) for the
PEGMEA/PEGDA monolithic column. Conditions: 59.3 cm × 75 µm i.d. monolithic
column; THF mobile phase operated under a constant pressure of 1500 psi, resulting in a
flow rate of 0.45 µL/min; online detection at 254 nm; in (A), toluene was used as a small
molecule to determine the total porosity of the column; the excluded pore was
approximately the intersection point of the interpolated straight lines corresponding to the
internal and external pore zones.
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The retention volumes shown in Figure 2.6 were the corrected retention volumes
taking into account the extracolumn volume of the chromatographic system, which was
measured to be 248 nL including the 60 nL internal sample loop. From Figure 2.6A, the
total porosity was calculated to be 75.4%, which is in agreement with the percent of
porogen content in the monomer recipe (monolith #4 in Table 2.1, 70% porogen). The
excluded molecular mass was estimated to be 104, which corresponds to 14 nm. The
external porosity was thus calculated to be 66.3% and the internal porosity was 9.1%.
The relatively large total porosity (75.4%) accounts for the low flow resistance of the
monolithic column.
The accumulated pore size distribution curve was derived from the ISEC
calibration curve, and is shown in Figure 2.6B. The pore volume fraction corresponding
to pores larger than 304 nm was 77.8% (not drawn in the figure), and 7.0% for pores
between 50 and 304 nm. The pore volume fraction for micropores (< 2 nm) was 10.9%,
and only 4.2% for mesopores (2 nm ~ 50 nm). It can be seen that most of the pore
volume fraction came from pores larger than 304 nm. The mesopore volume fraction was
very small (4.2%), and the pore volume fraction in the range of 1.4 ~ 10.8 nm was only
1.1%. Because the Stokes’ radius for proteins in the molecular mass range of 10 K ~ 70 K
is between 1.5 ~ 3.6 nm (data are from http://itsa.ucsf.edu/~hdeacon/Stokesradius.html),
the monolith would predict no separation of the proteins used in this study. This explains
the coelution of the proteins shown in Figure 2.5A. In contrast, the pore volume fraction
of micropores was relatively large (10.9%), and the curve (Figure 2.6B) in this pore size
range was sharp. These two characteristics explains the separation of peptides (Figure
2.5B). Although the molecular mass difference between proteins and peptides is huge, the
difference between the pore volumes corresponding to excluded proteins and peptides is
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nevertheless small, as can be seen in Figure 2.6B. This unique pore size distribution of
the monolith clarifies that α-chymotrypsinogen A coeluted with neurotensin (Figure
2.5C).
In summary, the PEGMEA/PEGDA column shows SEC elution of peptides and
proteins. The larger the molecule, the earlier the elution. However, due to the small pore
volume fraction in the mesopore range of the monolith, separation of proteins could not
be achieved for this monolithic column.

2.3.7

Protein Recovery Evaluation
To further evaluate the protein adsorption properties of the PEGMEA/PEGDA

monolith, a protein recovery experiment was performed. In conventional HPLC, the peak
areas of a compound eluted from a packed column and stainless steel tubing are
compared.25,29 Because a strong dependence of peak area on mobile phase flow rate was
observed in my capillary liquid chromatographic experiments, a direct comparison of the
protein peak areas from monolithic and open tubular fused silica capillaries would not
provide reliable data for calculating protein recovery. In contrast, the two detector
method30 or modified two detection window method31,32 in capillary electrophoresis
would be applicable for measuring protein recovery in the capillary format because peak
areas are measured in one run and variations in detector or detection window responses
are taken into account.
In my work, the two detection window method was used to perform recovery
experiments. Thiourea was used as an internal standard to calibrate the detection window
response variation. The recoveries for pepsin, BSA, myoglobin, α-chymotrypsinogen A,
and lysozyme were 98.0, 99.6, 103.5, 99.2, and 98.7%, respectively. This provided direct
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evidence that the PEGMEA/PEGDA monolith does not adsorb any significant amount of
proteins under the conditions of 100 mM phosphate buffer (pH 7.0) containing 0.5 M
NaCl.

2.4 Conclusions
A non-adsorptive monolith for proteins, PEGMEA/PEGDA, was prepared using
methanol and ethyl ether as porogens. Complete conversion of the monomer to the
polymer monolith could be finished in 10 min. The polymer monolith had very low flow
resistance, and was macroscopically homogeneous. Protein recovery approached 100% if
100 mM phosphate pH 7.0 buffer containing 0.5 M NaCl was used as mobile phase. No
significant ionic or hydrophobic interactions with proteins were found.
Another feature of this monolith is that it did not discriminate the elution of
several proteins (molecular weights from 14 K to 67 K) studied. Together with the
homogeneity and low flow resistance characteristics, the monolith would be very useful
in situations requiring an inert material for protein analysis, such as in flow counteracting
capillary electrophoresis33,34 or electric field gradient focusing,18 in which the required
hydrodynamic flow produces band broadening. By incorporating an inert material in the
separation channel, sharpening of the protein bands is expected while maintaining the
original separation/focusing mechanism. Currently, the incorporation of such a monolith
into the separation/focusing channels of electric field gradient focusing devices18 is under
investigation. For SEC of proteins using this monolith, a reduction in through-pore
diameter and optimization of the pore volume in the mesopore range must be
accomplished. Unfortunately, this would be accomplished with a concomitant increase in
flow resistance of the monolith.
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CHAPTER 3 EFFICIENT POLYMER MONOLITH FOR STRONG CATIONEXCHANGE CAPILLARY LIQUID CHROMATOGRAPHY OF PEPTIDES*

3.1 Introduction
Strong cation exchange (SCX) is an extremely important mode of ion exchange
chromatography for analyzing peptides and proteins.1 The utility of an SCX column,
which often contains sulfonic acid groups, lies in its ability to maintain negative charge
even under acidic buffer pH conditions (e.g., pH ~3). Under such conditions, most
peptides bear positive charge due to the presence of positively charged basic residues
(e.g., Arg, His and Lys), terminal amino groups, uncharged acidic residues (e.g., Glu and
Asp), and terminal carboxyl groups. SCX chromatography is, therefore, generally
applicable for peptide analysis when operated in acidic buffer pH. On the other hand,
when the buffer pH is in the neutral pH range, SCX can only be applied to the analysis of
basic peptides or proteins.
Particle based SCX columns received considerable interest for peptide analysis in
the 1980s because of the complementary selectivity to reversed-phase chromatography.2-9
For example, the retention of peptides on the PolySulfoethyl A SCX column was found
to be monotonically related to the charge of the peptides.5,7 Hodges et al.2 designed
several types of peptide standards to evaluate three commercially available SCX
columns. They found that retention of peptides was not only related to charge, but also
*

This chapter is reproduced with permission from Anal. Chem. 2006, 78, 3509-3518. Copyright 2006 American
Chemistry Society.
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peptide chain length. The retention of peptides was empirically linearized under
conditions in which hydrophobic interactions were suppressed. Peptide mapping of
protein digests was also investigated by the use of two or three-dimensional
chromatography, in which ion exchange was often followed by reversed-phase
chromatography.3,6,8,9
Monolithic materials have received considerable interest due to ease of
preparation and enhanced mass transfer.10-15 Excellent reviews11-13 have appeared
describing applications of polymer monoliths in liquid chromatography of both small
molecules and macromolecules. To date, a variety of polymer monoliths have been
developed,16-23 with efforts directed mainly towards reversed-phase chromatography.
Polymer monoliths have been extended to include SCX chromatography. To
introduce sulfonic acid groups into the monolith backbone, several approaches have been
reported, including adsorption of surfactants,24-26 grafting of a sulfonic acid-containing
monomer,27-29 functionalization of a reactive monolith with sodium sulfite,30 and
copolymerization.17,18,31-35 For example, surfactant (e.g., sodium dodecyl sulfate) has
been dynamically adsorbed into an in-situ synthesized polymer monolith by hydrophobic
interaction, where the other end of the surfactant serves as the SCX functional group.26
Although this approach was simple, it was demonstrated for ion exchange of small ions
only, likely due to the inherent strong hydrophobicity of the long surfactant chain.
Another method to introduce the sulfonic acid group is to graft a sulfonic acidcontaining monomer on a bulk polymer monolith.27-29 Svec et al.27 demonstrated the
feasibility of grafting 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS) onto
poly(butyl methacrylate-co-ethylene glycol dimethacrylate) monolith by photoinitiated
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hydrogen abstraction. Using catalyst initiated free-radical grafting polymerization,28
AMPS was also grafted into a hydrolyzed poly(glycidyl methacrylate-co-ethylene glycol
dimethacrylate) monolith, and the grafted monolith was successfully used for SCX of
proteins. Furthermore, thermally initiated grafting of a zwitterionic sulfobetaine into a
poly(trimethylolpropane trimethacrylate) monolith was also performed and investigated
for protein separation.29
Functionalization of a reactive monolith is another strategy to introduce a sulfonic
acid group. Ueki et al.30 synthesized a poly(glycidyl methacrylate-co-ethylene glycol
dimethacrylate) monolith. The reaction of the epoxy group in the glycidyl methacrylate
with sulfite introduced the desirable sulfonic acid functionality onto the polymer
monolith surface. The functionalized monolith was used for SCX of inorganic cations.
A more straightforward method to introduce the sulfonic acid group into a
polymer monolith is by copolymerization. A sulfonic acid-containing monomer was
copolymerized with a crosslinker in the presence17,18,31-34 or absence35 of a bulk
monomer. AMPS was copolymerized with a bulk monomer butyl methacrylate and a
crosslinker ethylene glycol dimethacrylate to generate electroosmotic flow in
electrochromatography.31,32 However, no attempts were made to use these monoliths for
SCX liquid chromatography. This is probably due to the low amount of AMPS used
(typically < 5%), which is insufficient for SCX of cations. The high percentage of butyl
methacrylate would also lead to unwanted strong hydrophobic interaction. Interestingly,
after ionic adsorption of aminated latex nanoparticles, such monoliths were successfully
demonstrated for ion exchange of small anions33 and saccharides.34
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Although direct copolymerization without the use of a bulk monomer is the
simplest method for monolith synthesis, the only reported example of this is the
copolymerization of 2-(sulfooxy)ethyl methacrylate and ethylene glycol dimethacrylate
for electrochromatography of peptides.35 However, due to the relatively low amount of 2(sulfooxy)ethyl methacrylate used in the monolith recipe (~17% total monomers), the
resulting monolith showed strong hydrophobicity. The separation of model peptides (2 or
3 residues) exhibited reversed-phase rather than ion exchange behavior.
The lack of reports on direct copolymerization of a sulfonic acid-containing
functional monomer with a crosslinker for SCX mainly results from two reasons. First, a
new optimization must be performed in order to obtain the new polymer monolith
although the composition of the monolith is simpler. Second, a sulfonic acid-containing
monolith is believed to swell excessively in aqueous buffer.30-32,34 Thus, the stability of a
monolith composed of a high percentage of sulfonic acid-containing monomer is
questionable. In this study, the preparation of a stable polymer monolith by direct
copolymerization of polyethylene glycol diacrylate and a high amount (40%) of AMPS
was demonstrated for SCX liquid chromatography of peptides for the first time. It was
hoped that this new polymer monolith could dramatically improve peak capacity of ion
exchange chromatography in which ion exchange of peptides is often considered
relatively slow and less efficient than reversed-phase liquid chromatography for
proteomics studies.36

3.2 Experimental Section
3.2.1

Chemicals and Reagents
2,2-dimethoxy-2-phenylacetophenone (DMPA, 99%), 3-(trimethoxysilyl)propyl

methacrylate (98%), AMPS, polyethylene glycol diacrylate (PEGDA, Mn ~258), and
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ethylene glycol dimethacrylate (EDMA) were purchased from Sigma-Aldrich
(Milwaukee, WI) and used without further purification. Synthetic peptide standard CESP0050 was obtained from Alberta Peptides Institute (Edmonton, Alberta, Canada).
Bradykinin fragment 1-7, peptide standard P2693 and its nine components were from
Sigma-Aldrich. Protein standards (myoglobin from equine skeletal muscle, cytochrome c
from bovine heart, and lysozyme from chicken egg white) were also obtained from
Sigma-Aldrich. Porogenic solvents for monolith synthesis and chemicals for mobile
phase buffer preparation were HPLC or analytical reagent grade.
For digestion of β-casein (Sigma-Aldrich), 1 mL of β-casein digestion solution,
which contained 50 µL of 1 M Tris pH 8.0 (99.9% purity, Fisher Scientific, Fair Lawn,
NJ), 10 µL of 0.1 M CaCl2 (EM Science, Cherry Hill, NJ), 20 µL of sequencing grade
modified trypsin (Promega, Madison, WI), 100 µL of 2 mg/mL β-casein, and 820 µL of
Mili Q water, was incubated at 37 ºC in a Shake’ N’ Bake hybridization oven (Boekel
Scientific, Feasterville, PA ) overnight. The digest was quenched by acidifying with
formic acid. The β-casein digest was then desalted using a Strata-X 33 µm polymeric
sorbent column (Phenomenex, Torrance, CA), following the manufacturer’s protocol.
The eluent from the desalting column was lyophilized in a Centrivap cold trap
(LabConco, Kansas City, MO), re-suspended in 20 µL of gradient elution starting buffer,
and centrifuged using an Eppendorf centrifuge (Brinkmann, Westbury, NY) at 10,000
rpm for 3 min before injection.

3.2.2

Polymer Monolith Preparation
Before filling the UV transparent capillary (75 µm i.d., 360 µm o.d., Polymicro

Technologies, Phoenix, AZ) with monomer solution, the capillary inner surface was
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treated with 3-(trimethoxysilyl)propyl methacrylate to ensure covalent bonding of the
monolith to the capillary wall.37 The bulk monomer solution was prepared in a 1 dram (4
mL) glass vial by mixing 0.008 g DMPA, 0.32 g AMPS, 0.48 g PEGDA, 0.20 g water,
0.55 g methanol and 1.70 g ethyl ether. The monomer mixture was vortexed and
ultrasonicated for 5 min to help dissolve AMPS and eliminate oxygen. Because of its low
viscosity, the monomer solution was introduced into the UV transparent capillary by
capillary surface action. The capillary (22 cm total length and 16.5 cm monomer length,
unless otherwise specified) was then placed perpendicular to a UV dichroic mirror from
Navitar (Newport Beach, CA), which was operated 45o directly under a Dymax 5000AS
UV curing lamp (Torrington, CT) for 3 min. The resulting polymer monolith inside the
capillary was connected to an HPLC pump, and flushed with methanol and water
sequentially to remove porogens and any unreacted monomers. The prepared polymer
monolith was then equilibrated with buffer solution before use. Care was taken to avoid
drying the monolith by storing it filled with water or mobile phase. After the completion
of all chromatographic experiments, a small section (2 cm) of the monolith inside the
capillary was dried under vacuum for scanning electron micrography (SEM) analysis
(FEI Philips XL30 ESEM FEG, Hillsboro, OR).38 The same procedure was also applied
to synthesize poly(AMPS-co-EDMA) monoliths.

3.2.3

Capillary Liquid Chromatography (CLC)
CLC of peptides was performed using a system previously described, with some

modifications.38 Briefly, two ISCO Model 100 DM syringe pumps with a flow controller
(Lincoln, NE) were used to generate a two-component mobile phase gradient. Due to the
nL/min flow required for the monolithic capillary, the gradient flow from the pump was
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split with the use of a Valco splitting tee (Houston, TX), which was installed between the
static mixer of the syringe pumps and the 60 nL Valco internal loop sample injector. A 33
cm long capillary (30 µm i.d.) was used as the splitting capillary, and a 5 cm long
capillary (30 µm i.d.) was connected between the splitting tee and the injector to
minimize extracolumn dead volume. The mobile phase flow rate was set at 69 µL/min.
The actual flow rate in the monolithic capillary column was measured by monitoring
movement of a liquid meniscus through 100 cm long open tubular capillary (75 µm i.d.),
which was connected to the monolithic capillary using a Teflon sleeve (Hamilton, Reno,
NV). Depending on the mobile phase used, the flow rate in the monolithic capillary was
70-100 nL/min, resulting in split ratios from 700:1 to 1000:1.
For CLC of peptides with gradient elution, mobile phase A was a 5 mM
phosphate buffer (pH 2.7 or 7.0) with various amounts of acetonitrile. Mobile phase B
was the same composition as mobile phase A plus 0.5 M NaCl, and a gradient rate of 15% B/min was typically used. All mobile phases were filtered through a 0.2 µm Nylon
membrane filter (Supelco, Bellefonte, PA) and ultrasonicated before use. The apparent
pH of the mobile phase was measured using a pH meter (Omega, Stamford, CT). Oncolumn UV detection was performed at 214 nm. Chromatograms were transferred to an
ASCII file and redrawn using Microcal Origin (Northampton, MA). The monolithic
column was also used for CLC of proteins using aqueous buffers.
For measurement of the dynamic binding capacity of the monolithic column, 1
mg/mL bradykinin fragment 1-7 in 5 mM phosphate containing 40% acetonitrile (pH 2.7)
was pumped under constant pressure of 2000 psi through the monolithic column (18.6 cm
long, 75 µm i.d.) using one syringe pump. No splitter was used for these measurements.
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Because of the low amount (<1 mL) of the bradykinin fragment 1-7 solution available, it
was preloaded into a sample loop capillary (2 m long, 320 µm i.d.), with one end
connected to the Valco injector and the other end to the monolithic column using
Upchurch unions (Oak Harbor, WA). The flow rate was measured to be 91 nL/min.
Following the same procedures, the dynamic binding capacity based on uptake of protein
(cytochrome c) was also performed on a new monolithic column (7 cm long, 75 µm i.d.).
A solution of 4 mg/mL cytochrome c in 5 mM phosphate (pH 6.2) was pumped through
the column under constant pressure of 850 psi, resulting in a column flow rate of 91
nL/min.
For studying the swelling/shrinking properties of the polymer monolith, different
organic solvents were pumped through a 10 cm long monolith segment inside a capillary
at different pressures. A splitter and detector were not used for these measurements. The
flow rate was measured as described above.
Safety Considerations. AMPS monomer is listed as a suspected carcinogen, and
PEGDA is a sensitizing agent. Appropriate MSDS information should be consulted for
physical handling of these materials. Sunglasses that block UV light and gloves should be
worn to avoid sunburns caused by the high power UV curing system during the
preparation of the monolith.

3.3 Results and Discussion
3.3.1

Polymer Monolith Preparation
AMPS, a commercially available acrylamido derivative, was chosen as monomer

to synthesize the SCX monolithic column because it contains the desirable sulfonic acid
group. PEGDA, which is an acrylate based crosslinker with three ethylene glycol units,
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has been shown to resist adsorption of peptides and proteins.38 Therefore, it was selected
as crosslinker for the synthesis of the monolith. PEGDA was used instead of EDMA as
crosslinker to prepare a monolith with more hydrophilicity.
The most widely used porogen strategy was adopted to control the through-pores
in the monoliths in this study. To date, choice of porogens has been mainly achieved by
trial-and-error, although some theoretical aspects for porogen selection have been derived
for macroporous particle synthesis using suspension polymerization.39-41 Because the
solubility of AMPS in common organic solvents is low, water was selected as one of the
porogens to help dissolve AMPS. Methanol was selected as another porogen because it
was proven efficient for the formation of macroporous through-pores in a poly(PEGDA)
monolith.38 Unfortunately, any combination of water and methanol (with 0.32 g AMPS
and 0.48 g PEGDA) yielded a nonporous or microporous translucent gel structure which
allowed no flow of mobile phase. The same results were also observed for combination
of water, methanol and 1-propanol. Since ethyl ether is another powerful porogen for
PEG-based monoliths,38 it was finally chosen as the third porogen. After simple
optimization, a recipe (25% monomers, composed of 40:60 wt% AMPS and PEGDA,
and 75% porogens, composed of 8:23:69 wt% water, methanol and ethyl ether) was
finalized, and the resulting monolith supported considerable flow under moderate
pressure in aqueous buffer. Noteworthy was the incorporation of 40% AMPS, which
represents the highest reported percentage of AMPS copolymerized into a polymer
monolith backbone. Due to the one-step in-situ synthesis protocol, the rate of success in
preparing such monolithic capillary columns approached 100%.
A scanning electron micrograph of the optimized monolith is shown in Figures
3.1A and 3.1B. It can be immediately observed that the morphology of the
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A
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Figure 3.1. SEM images of several monoliths synthesized. (A) Optimized poly(AMPSco-PEGDA) monolith used in this study (scale bar = 20 µm); (B) higher magnification of
the monolith in (A) (scale bar = 2 µm); (C) poly(AMPS-co-PEGDA) monolith that has
the same composition as (A) except that methanol and ethyl ether were 0.85 and 1.40 g,
respectively (scale bar = 2 µm); (D) poly(AMPS-co-EDMA) monolith (recipe: 0.008 g
DMPA, 0.35 g AMPS, 0.40 g EDMA, 0.35 g water, 1.10 g methanol, scale bar = 2 µm).
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poly(AMPS-co-PEGDA) monolith is unique. It was composed of fused microglobules,
with no distinct microspheres. It appeared intermediate between a conventional polymer
monolith with a distinct particulate structure11-13 and a silica monolith with a skeletal
structure.14-15 The through-pores of the monolith were obvious. Cracks along the
circumference of the monolith (Figure 3.1A) were presumably due to shrinking of the
monolith upon drying when SEM images were taken.
To explore variables that could result in the formation of this unique morphology,
two other monoliths were prepared and their SEM images are shown in Figures 3.1C and
3.1D. With an increase in methanol in the porogen composition, conventional polymer
monolithic morphology with discrete and more “regular” microglobules was formed
(Figure 3.1C). If EDMA was used as crosslinker, the resulting poly(AMPS-co-EDMA)
monolith exhibited similar fused but more porous structure (compare Figures 3.1B and
3.1D). Based on these micrographs, it seems that porogens rich in methanol or the use of
EDMA as crosslinker favored the formation of conventional polymer monolithic
morphology, while a monolith formed from porogens rich in ethyl ether, or that used
PEGDA as crosslinker tended to form a fused structure. Both porogen and crosslinker are
important factors that control the morphology of poly(AMPS) monoliths.

3.3.2

Effect of Acetonitrile on the Elution of Synthetic Peptides
An ideal SCX column for LC of peptides should be moderately hydrophilic, able

to retain weakly charged analytes (e.g., +1 charged peptides), and exhibit retention of
analytes independent of buffer pH from acidic to neutral.2 In addition, high binding
capacity is another favorable feature which improves peptide resolution.
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Table 3.1. Properties of synthetic peptides.
Analyte

Amino acid sequencea

1

Ac-Gly-Gly-Gly-Leu-Gly-Gly-AlaGly-Gly-Leu-Lys-amide
Ac-Lys-Tyr-Gly-Leu-Gly-Gly-AlaGly-Gly-Leu-Lys-amide
Ac-Gly-Gly-Ala-Leu-Lys-Ala-LeuLys-Gly-Leu-Lys-amide
Ac-Lys-Tyr-Ala-Leu-Lys-Ala-LeuLys-Gly-Leu-Lys-amide

2
3
4
a

Charge
at pH 2.7
+1

Charge
at pH 7.0
+1

Hydrophobicity
index at pH 2.0b
14.7

Hydrophobicity
index at pH 7.0c
18.6

+2

+2

17.5

23.4

+3

+3

21.4

30.2

+4

+4

24.2

35.0

Amino acid sequence was from ref [42]. Ac = Να-acetyl; Amide = Cα-amide. Positively charged residues are indicated in bold

font. b Hydrophobicity index was calculated based on ref [43]. c Data were from ref [42].

88

Hodges et al.2,42 designed several synthetic peptides to evaluate particle based
SCX columns. The synthetic peptide standard, CES-P0050, was composed of four
peptides (see Table 3.1) which possess certain characteristics for SCX column evaluation.
These peptides are all undecapeptides having similar chain length to those most
commonly encountered in protein tryptic digests, and they do not have any acidic
residues (the C-terminal groups are amides), so they possess the same charge in acidic to
neutral buffers. The hydrophobicity index of these peptide standards has been compiled
for pH 7.0.42 However, they were re-tabulated in Table 3.1 for easy reference, along with
other properties (e.g., amino acid sequence).
Figure 3.2 shows a gradient elution chromatogram of the synthetic peptides under
different buffer conditions using the poly(AMPS-co-PEGDA) monolithic SCX column.
With an increase in acetonitrile in the mobile phase from 0% to 40% (see Figures 3.2A to
3.2E), the elution times for peptides 1-4 were monotonically decreased. For peptide 4,
addition of 40% acetonitrile in the elution buffer was required to suppress hydrophobic
interactions (compare Figures 3.2D and 3.2E). For the less hydrophobic peptides 2 and 3,
20-30% acetonitrile could effectively eliminate hydrophobic interactions, as evidenced by
the very sharp peaks obtained. For the least hydrophobic peptide 1, no acetonitrile was
required because no significant hydrophobic interactions were observed. The minor
differences in retention times for peptide 1 were likely due to differences in mobile phase
column flow rate. The dramatic decrease in retention time and improvement in peak
shape for peptide 4 indicates relatively strong hydrophobicity of the poly(AMPS-coPEGDA) monolith. This feature is not desirable for two-dimensional LC (e.g., ion
exchange followed by reversed-phase) for proteomics, in which an aqueous buffer
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Figure 3.2. SCX chromatography of synthetic peptides. Conditions: 16.5 cm × 75 µm i.d.
monolithic column; buffer A was 5 mM NaH2PO4 (pH 2.7) and buffer B was buffer A
plus 0.5 M NaCl, both buffers containing 0, 10, 20, 30, or 40% (v/v) acetonitrile (panels
A, B, C, D, and E, respectively); 2 min isocratic elution of 1% B, followed by a linear AB
gradient (5% B/min, equating to 25 mM salt/min) to 100% B and various times of
isocratic elution of 100% B until peptide 4 was eluted; ~10 min gradient delay time;
mixture of peptides 1-4 (see Table 3.1 for sequence) in CES-P0050, which was dissolved
in 400 µL buffer A with 0% acetonitrile, resulting in a concentration of 0.44 mM for
peptide 3; 69 µL/min pump master flow rate; 76, 83, 85, 89 or 100 nL/min column flow
rates (panels A, B, C, D, and E, respectively); online UV detection at 214 nm.
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without acetonitrile is required in the first dimension to effect retention of peptides in the
second dimension before separation.
The relatively strong hydrophobicity of the poly(AMPS-co-PEGDA) monolith
was surprising. The biocompatible crosslinker PEGDA was specially designed and used
to decrease unwanted polymer backbone hydrophobicity. To further confirm the
biocompatibility of PEGDA, a poly(PEGDA) monolith was prepared following a
previously published protocol,38 and peptides 1-4 were eluted from the monolith using
buffers containing various amounts (0-40%) of acetonitrile. Results (data not shown)
indicated negligible differences in peptide elution with the use of different buffers.
Therefore, the relatively strong hydrophobicity of the poly(AMPS-co-PEGDA) monolith
must be due to the monomer AMPS itself. In fact, the AMPS molecule contains an
isobutyl arm, which connects to the sulfonic acid group on one end and the acrylamido
group on the other end. Alpert et al.5 found that PolySulfoethyl A columns were superior
to the more hydrophobic sulfopropyl columns.8,9 In analogy, it is expected that the
monolithic sulfobutyl phase possesses stronger hydrophobicity than desired due to the
butyl segment in the side groups.
Despite the strong hydrophobicity of the poly(AMPS-co-PEGDA) monolith, it
was shown to retain strongly the +1 charged peptide (see Figure 3.2E). This positive
feature is uncommon for commercially available particulate SCX columns where only the
PolySulfoethyl A column could retain the peptide.2,42 For 40% acetonitrile, where any
hydrophobic interaction was greatly eliminated, retention of the peptide on the monolith
would be expected from ionic interaction only. This strong ionic interaction can be
attributed to the use of a high amount of AMPS (40%) in the copolymerization.
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With hydrophobic interactions suppressed (i.e., with the use of 40% acetonitrile),
the four synthetic peptides were eluted as extremely sharp peaks (see Figure 3.2E), with
an average peak width at baseline of 0.28 min. According to the simple definition of peak
capacity in gradient elution (peak capacity = time of gradient/peak width),44 the peak
capacity was calculated to be 71, a value surpassing most particulate based SCX
columns1-9 (peak capacities of 24~66 were estimated based on several chromatograms
provided in these references) and other polymer monolithic SCX columns10,28,30,33,34
[Peak capacities of 5~32 were again estimated; in cases of isocratic elution, the peak
capacity was calculated as n = ( N 4) ln(t 2 / t1 ), where N is the column efficiency, and t2
and t1 are the retention times of the last and the first eluting peaks, respectively]. The
asymmetry factors calculated at 10% peak height for peptides 1-4 were 1.01, 0.94, 0.90,
and 0.99, respectively. The sharp peaks together with minimal fronting or tailing
indicated a highly efficient SCX monolithic column.
The run-to-run reproducibility of the poly(AMPS-co-PEGDA) column was good.
For three consecutive runs using conditions the same as in Figure 3.2E, the relative
standard deviation (RSD) of the retention times for peptides 1-4 were 1.9, 0.7, 0.3, and
0.4%, respectively. For peak height, the RSD values for peptides 1-4 were 4.6, 2.3, 2.0
and 1.7%, respectively. These data clearly demonstrate that good reproducibility could be
readily achieved if the column was equilibrated with starting buffer for a sufficient period
(typically ~10 column volumes) between runs, although the polymer monolith exhibited
swelling in aqueous buffers (vide infra).
Column-to-column reproducibility measurements gave retention time RSD values
(n=3) for peptides 1-4 of 1.3, 1.6, 2.2, and 2.4%, respectively. However, significant
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deviation was observed for peak height measurements; the RSD values for peptides 1-4
were 18.5, 18.6, 34.6, and 21.9%, respectively.

3.3.3

Effect of Buffer pH on the Resolution of Synthetic Peptides
With an increase in buffer pH from 2.7 to 7.0, greater retention with similar sharp

peaks was observed for synthetic peptides 1-4 under otherwise identical conditions as in
Figure 2.2E (data not shown). Because the peptides bear the same charges in both buffer
pHs (see Table 3.1), this indicates an increased negative charge density of the monolith
upon an increase in buffer pH. Although AMPS is a strong organic acid with pKa of
1.2,45 the pKa of poly(AMPS) shifts to a higher value due to the absence of electronwithdrawing vinyl groups upon polymerization.46 An increase in metal-poly(AMPS)
retention was observed with an increase in buffer pH from 1 to 7.47 Thus, the lower
acidity of poly(AMPS) over AMPS accounts primarily for the increased retention of
peptides at pH 7.0 compared to pH 2.7. Another contributing factor is the presence of
acrylic acid, an impurity found in both AMPS and PEGDA monomers, which can be
copolymerized into the monolith backbone. However, no confirmation of this was sought.
The stronger retention of peptides upon increase of buffer pH was also observed for most
particulate based SCX columns.2

3.3.4

Dynamic Binding Capacity
One of the most important properties of an ion exchange column is the binding

capacity,48 which determines the resolution, column loadability, and gradient elution
strength. For the measurement of dynamic binding capacity of an SCX column, proteins
(e.g., lysozyme or hemoglobin) are often used. Although the monolithic column could
elute and separate proteins using buffers with high ionic strength (vide infra), it did not
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elute lysozyme, cytochrome c or hemoglobin within 2 h under conditions typical for SCX
chromatography of peptides [e.g., 5 mM phosphate (pH 2.7) containing 40% acetonitrile
and 0.5 M NaCl]. Therefore, bradykinin fragment 1-7, which bears +2 charge at pH 2.7,
was used to determine the monolithic column dynamic binding capacity. During frontal
analysis, a sharp increase in baseline was observed, indicating fast kinetic interaction of
the peptide with the column. With the use of 1 mg/mL peptide, it took an amazingly long
time (1074 min) to saturate the column. Based on the measured flow rate of 91 nL/min,
the dynamic binding capacity was 119 mg/mL, corresponding to 157 µequiv/mL. From
the monolith recipe (see Section 3.2.2), this 40% AMPS / 60% PEGDA monolith had a
theoretical binding capacity of 475 µequiv/mL. This indicates that ~33% of AMPS in the
monolith backbone was accessible for ionic interaction. The major portion (67% in this
case) of AMPS is most likely buried in the polymer monolith, due to the direct
copolymerization method used. Nevertheless, the dynamic binding capacity of the
poly(AMPS-co-PEGDA) monolith was high. This was supported by the elution of the +4
charged peptide 4 as shown in Figure 3.2E after a 20 min gradient step. For simple
comparison with other SCX columns, the dynamic binding capacity was also measured
based on cytochrome c uptake although such measurement might be inappropriate and
inaccurate due to hydrophobic binding. It took 282 min to saturate the 7 cm long
monolith, resulting in a binding capacity of 332 mg/mL.
The dynamic binding capacity of this monolith was compared with other columns.
Alpert et al.5 reported that the PolySulfoethyl A column had a dynamic binding capacity
of 100 mg hemoglobin/mL packing material, corresponding to ~3 µequiv/mL. Because
157 µequiv peptide/mL or 332 mg protein/mL was achieved for the current monolithic
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column, the binding capacity was greater than that of the PolySulfoethyl A column. For
the poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monoliths28,29 grafted
with AMPS for SCX chromatography of proteins, the dynamic binding capacity was
found to be typically lower than 100 mg protein/g monolith. For the functionalized
poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monolith,30 the dynamic
binding capacity was 90-300 µequiv/mL, albeit based on copper ion uptake. The binding
capacity was very low (~1 µequiv/mL) for the anion exchange polymer monolith,33
which was prepared by agglomeration of aminated latex particles to a monolith prepared
through the copolymerization of a small amount of AMPS, a large amount of BMA and
EDMA. This was presumably due to the lower amount of AMPS used in the
copolymerization. In summary, the dynamic binding capacity of the current monolith,
which was prepared from direct copolymerization of 40% AMPS and 60% PEGDA, was
greater than the particulate-based SCX PolySulfoethyl A column and most of the other
polymer monolithic SCX columns.

3.3.5

SCX Chromatography of a Complex Peptide Mixture
To demonstrate the general utility of the poly(AMPS-co-PEGDA) monolith for

peptide analysis, a more complex peptide mixture P2693 composed of 9 natural peptides
(see Table 3.2) was chromatographed using buffer containing 40% acetonitrile under
different gradient rates (Figure 3.3). As seen in Figure 3.3A, 7 out of the 9 peptides were
resolved when 5% B/min gradient rate was used. By decreasing the gradient rate to 2%
B/min, 8 peaks were baseline separated (Figure 3.3B). A further decrease in the gradient
rate to 1% B/min resolved all 9 peptides, although peptides 2 and 3 were not baseline
separated (Figure 3.3C and inset). Thus, it is convenient to use a shallow gradient to
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Table 3.2. Properties of the nine peptides in the P2693 standard.
No

Analyte

Amino acid sequencea

Molecular
weight

No. of
residues

Charge at
pH 2.7

Hydrophobicity
index at pH 2.0b

1

Oxytocin

1007.19

9

+1

19.5

2

Methionine
enkephalin
Leucine enkephalin
Bombesin

Cys-Tyr-Ile-Gln-Asn-Cys-ProLeu-Gly-NH2
Tyr-Gly-Gly-Phe-Met

573.70

5

+1

10.0

Tyr-Gly-Gly-Phe-Leu
pGlu-Gln-Arg-Leu-Gly-AsnGln-Trp-Ala-Val-Gly-His-LeuMet-NH2
pGlu-His-Trp-Ser-Tyr-Gly-LeuArg-Pro-Gly

555.62
1619.85

5
14

+1
+2

12.6
34.9

1183.27

10

+2

20.4

Cys-Tyr-Phe-Gln-Asn-Cys-ProArg-Gly-NH2
Arg-Pro-Pro-Gly-Phe

1084.23

9

+2

11.5

572.66

5

+2

7.5

Arg-Pro-Lys-Pro-Gln-Gln-PhePhe-Gly-Leu-Met-NH2
Arg-Pro-Pro-Gly-Phe-Ser-ProPhe-Arg

1347.70

11

+3

27.9

1060.20

9

+3

16.8

3
4

5

6
7

Luteinizing
hormone releasing
hormone
[Arg8]-Vasopressin

8

Bradykinin
fragment 1-5
Substance P

9

Bradykinin

a

Amino acid sequence was from Sigma website. Positively charged residues were indicated in bold font. Free N-terminal bears +1

charge while pyroed N-terminal with glu (pGlu) is neutral. b Hydrophobicity index was calculated based on ref [43].
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Figure 3.3. SCX chromatography of natural peptides. Conditions were the same as those
in Figure 3.2E with the following exceptions: mixture of nine natural peptides (see Table
3.2) dissolved in 25 µL buffer A to make each peptide ~1 mg/mL; gradient rate of (A)
5% B/min; (B) 2% B/min; (C) 1% B/min.
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improve resolution for analyzing complex samples. The separation shown in Figure 3.3C
was governed by an ion exchange mechanism. Following the empirical relationship
between retention time and charge-to-chain length ratio developed by Hodges et al.,2 a
straight line [tR = 66.03 × N/ln(n) - 2.05] was obtained with a regression coefficient of
0.96, where tR is the peptide retention time, N is the charge, and n is the number of amino
acid residues. This confirmed a pure ionic interaction of the polymer monolith for SCX
of natural peptides with 5 to 14 residues and a hydrophobicity range from 7.5 to 34.9 (see
Table 3.2).
It is interesting that the elution order in Figure 3.3C is the reverse of that in
capillary zone electrophoresis (CE) (cf technical bulletin for P2693 from Sigma,
http://www.sigmaaldrich.com/sigma/datasheet/p2693dat.pdf) except for peptides 7 and 8.
This is not unexpected because retention in SCX is based on the charge-to-ln(chain
length) ratio while in CE, migration is determined by analyte charge-to-size ratio. Thus,
an analyte with more charge and smaller size will migrate earlier in CE, and elute later in
SCX. As compared with separation in CE, better resolution (with the exception of
peptides 2 and 3) was generally obtained for SCX chromatography, although longer time
was required. Peak widths were somewhat narrower in SCX chromatography than in CE.
This demonstrates that comparable or better resolution and efficiency were achieved for
peptide analysis with the use of the poly(AMPS-co-PEGDA) monolithic column than for
CE.
The average peak width at baseline in Figures 3.3A (excluding the second peak
due to coelution of three peptides), 3B (excluding the second peak due to coelution of
two peptides) and 3C (excluding the second and third peaks due to incomplete resolution)
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were 0.27, 0.38 and 0.56 min, resulting in peak capacities of 74, 130 and 179 for the
gradient rates of 5%, 2% and 1% B/min, respectively. As discussed above, the peak
capacity calculated from Figure 3.2E was 71 where a gradient rate of 5% B/min was used
for SCX of four synthetic peptides. It seems that the peak capacity depends on the salt
gradient rate and not on the analytes used. A shallower gradient resulted in a greater peak
capacity. This was due to the use of the unique monolith, for which the peak width
increased less proportionally upon an increase in the gradient elution time. This feature is
attractive for resolving complex peptide samples (e.g., protein digests).
Noteworthy was the resolution between methionine enkephalin and leucine
enkephalin (inset in Figure 3.3C). These two peptides bear the same charge and have the
same chain length (see Table 3.2). They also have very similar molecular weight and
hydrophobicity. Due to the use of 40% acetonitrile in the mobile phase, it is not likely
that the resolution was based on differences in hydrophobicity. Instead, the separation
was primarily due to differences in ionic interaction resulting from a minor difference in
molecular weight. Because methionine enkephalin has a greater molecular weight than
leucine enkephalin, the ionic interaction between methionine enkephalin and the
monolith would be expected to be somewhat smaller, leading to earlier elution. The
successful separation of methionine enkephalin and leucine enkephalin emphasizes the
exceptional resolution provided by the poly(AMPS-co-PEGDA) monolith.
Further evaluation of the monolith was conducted for SCX chromatography of a
β-casein digest (Figure 3.4). Once again, very nice separation was obtained. Based on
several completely resolved peaks (indicated on Figure 3.4), the peak capacity was
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Figure 3.4. SCX chromatography of β-casein digest. Conditions were the same as in
Figure 3.3C.
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estimated to be 167, close to 179 measured using peptide standard P2693. This confirmed
that peak capacity was not dependent on the sample analyzed, but on the gradient rate. It
should be mentioned that the protein digest had to be desalted. If the β-casein digest was
not desalted (see Section 3.2.1), the peptides coeluted in 15 min (data not shown). This is
expected because peptides will not be strongly retained if they are dissolved in a high
concentration of salt buffer. During the experiment, it was also important to use freshly
prepared peptides and to store them in a refrigerator. For example, peptide standard CESP0050 degraded if dissolved in the starting buffer and stored at 2-8 oC for more than 2
months. Figure 3.5 shows a separation of a degraded sample. In addition to the main four
peptides, eight other peptides could be clearly seen. This, once again, demonstrates the
high resolution of the poly(AMPS-co-PEGDA) monolith for SCX liquid chromatography
of peptides. It opens the possibility of using SCX chromatography for quality analysis
(e.g., purity) of peptides, although such analyses are almost exclusively performed using
reversed-phase liquid chromatography.

3.3.6

SCX Chromatography of Protein Standards
Attempt was also made to perform SCX chromatography of basic proteins, and

the result is shown in Figure 3.6. As mentioned before, proteins did not elute from the
monolithic column when 5 mM phosphate (pH 2.7) containing 40% acetonitrile and 0.5
M NaCl was used as eluent. This is likely due to stronger binding of proteins than
peptides, as confirmed by the elution of proteins when NaCl concentration was increased
to 2.0 M. However, due to the poor solubility of NaCl in 40% acetonitrile, a buffer that
contains no acetonitrile must be used. Thus, the separation in Figure 3.6 was based on a
mixed-mode mechanism. An increase in buffer salt concentration resulted in a decrease
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Figure 3.5. SCX chromatography of old synthetic peptide sample. Conditions were the
same as in Figure 3.2E.
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Figure 3.6. SCX chromatography of proteins. Conditions were the same as in Figure 3.2E
except that different buffers were used; buffer A was 5 mM phosphate (pH 6.2) and
buffer B was buffer A plus 2.0 M NaCl; analytes: (1) myoglobin, (2) cytochrome c, and
(3) lysozyme. The baseline drift during gradient elution and the rise of the baseline at the
end of gradient were due to the difference in UV absorbances of buffers A and B.
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in ionic interaction and an increase in hydrophobic interaction. As a result, protein peaks
were broadened by the increased nonspecific hydrophobic interaction during salt gradient
elution. Although the SCX column exhibited worse chromatographic performance for
proteins than for peptides, it was comparable to other monolithic SCX columns for
protein analysis.28

3.3.7

Stability of the Poly(AMPS-co-PEGDA) Monolith
Permeability is a good index to reflect swelling or shrinking of the monolith. If a

monolith swells, its through-pores will decrease in size, resulting in lower permeability,
and vice versa. From Table 3.3, the permeability was approximately an order of
magnitude lower in aqueous buffer than in some organic solvents. With the use of
organic solvents, the permeability decreased roughly with an increase in solvent relative
polarity, except that ethyl ether and acetone had the highest permeability. This indicates
that the monolith swells in more polar solvents and shrinks in less polar solvents.
Although the poly(AMPS-co-PEGDA) monolith swelled in aqueous buffer and
shrank in organic solvents, no detachment of the monolith from the capillary wall was
observed under any condition, likely due to covalent attachment to the capillary wall.
Furthermore, the column flow rate reached a constant value after equilibration with a new
solvent. This indicated reversible shrinking or swelling of the monolith under a variety of
solvent conditions. For the SCX liquid chromatography of peptides reported in this study,
the column flow rate measured was 70-100 nL/min when the backpressure read from the
pump panel was between 2000 and 2300 psi during the gradient run. This indicates that a
considerable flow was generated at moderate pressure even though the monolith swelled.
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Table 3.3. Permeability of the poly(AMPS-co-PEGDA) monolith.
Flushing fluid
Hexane
Ethyl ether
THF
Acetone
Acetonitrile
Methanol
Water
Buffer A
Buffer B
a

Relative polaritya
0.009
0.117
0.207
0.355
0.460
0.762
1.000
/
/

Viscosity, η
(cP)b
0.300
0.224
0.456
0.306
0.369
0.544
0.890
0.846
0.890

Column backpressure,
∆p (psi)
800
800
800
800
800
800
1200
1200
1200

Linear velocity, u
(mm/s)
5.52
12.09
2.51
9.09
3.30
1.17
0.27
0.33
0.47

Permeability, k
(×10-15 m2)c
30.0
49.1
20.8
50.4
22.1
11.5
2.9
3.4
5.1

Relative polarity data were from http://virtual.yosemite.cc.ca.us/smurov/orgsoltab.htm. b Viscosity data were from online CRC

Handbook of Chemistry and Physics, 85th edition, 2004-2005. For buffer A which contains 40% aceonitrile, the viscosity is ~95%
water (Sadek, P. C., in HPLC Solvent Guide, 2nd ed., John Wiley and Sons: New York, 2002). For buffer B which contains both 40%
acetonitrile and 0.5 M NaCl, the viscosity is assumed to be 0.89×0.95×1.052 = 0.890 because 0.5 M NaCl is 1.052 times the viscosity
of pure water. c Permeability k = ηLu/∆p, where η is the viscosity, L is the column length (10 cm in this case), u is the solvent linear
velocity, and ∆p is the column backpressure.
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The polymer monolith could be used continuously over 1 month under a pressure of
>2000 psi. Excessive swelling of the sulfonic acid-containing polymer monolith in
aqueous buffer, which would result in no flow, was not observed for the poly(AMPS-coPEGDA) monolith reported in this study.

3.3.8

Tentative Explanation of the Sharp Peaks Obtained
It is interesting that the permeabilities of the monolith in aqueous buffers A and B

were different (see Table 3.3). An increase in permeability was observed with the use of
the same buffer with 0.5 M NaCl additive. This reflects a responsive property of the
poly(AMPS-co-PEGDA) monolith upon contact with salt. Viklund et al.29 reported that
poly(TRIM) monolith with a surface grafted with SPE showed a salt dependant
permeability. However, the permeability decreased with an increase in NaCl
concentration in the range of 0-0.2 M. Interestingly, no such trend was observed for the
monolith prepared by copolymerization of TRIM and SPE.
The salt dependant permeability of the poly(AMPS-co-PEGDA) monolith is
expected to have an influence on the chromatography of peptides. The mobile phase flow
rate in the monolithic column increased in my system during the salt gradient run because
the nano flow gradient in the column was generated by a passive splitter (see Section
3.2.3). Thus, two gradients effected the elution of peptides from the monolithic column.
One was a simple salt gradient, which narrowed the peptide bands during elution. The
other was a naturally formed flow gradient. The flow gradient would provide an
effectively sharper salt gradient than set in the program. As seen in Figure 3.3, the
sharper the salt gradient, the narrower the peak widths. Double gradient elution was
previously demonstrated in ion exchange liquid chromatography of small ions, where a
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flow gradient was intentionally employed to achieve fast separation.49 It should be
emphasized that although a natural flow rate gradient existed in these studies, it did not
contribute significantly to the sharpening of peptide bands, especially under shallow (e.g.,
1% B/min) salt gradient conditions, where a flow rate increase of ~1.4 times (based on
Table 3.3) was estimated for a 100 min interval.
It is hypothesized that the extremely sharp peaks achieved in this study are
primarily due to the nature of the poly(AMPS-co-PEGDA) monolith. While the
poly(AMPS-co-PEGDA) monolith was shown to exhibit strong hydrophobicity, the
hydrophobicity was mainly derived from the side chains of the monolith that attached the
functional AMPS monomer. The backbone of the polymer monolith contributed
negligible hydrophobicity due to the use of both a biocompatible crosslinker PEGDA and
a biocompatible acrylamido group in the AMPS. Thus, no nonspecific hydrophobic
interaction between the polymer backbone and peptide would occur. Because the side
chains are located on the surface of the polymer monolith upon contact with aqueous
buffer, mass transfer resistance would be small, resulting in high column efficiency. To
test this hypothesis, SCX chromatography of synthetic peptides 1-4 on a poly(AMPS-coEDMA) monolith was performed under the same conditions as in Figure 3.2E. Although
well separated, the peaks for all four peptides were broad and tailing (data not shown).
This observation confirms that the extremely narrow peaks obtained in this study were
primarily due to the use of the biocompatible crosslinker PEGDA.

3.4 Conclusions
A poly(AMPS-co-PEGDA) monolith containing as high as 40% AMPS was
prepared by one-step copolymerization. The monolith had several favorable features,
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such as high binding capacity, extraordinarily high resolution and high peak capacity,
making it ideal for resolving complex peptide samples, such as protein digests. Due to its
excellent chromatographic performance and ease of preparation, the poly(AMPS-coPEGDA) monolith is expected to find many applications.
A unique structural feature of the new monolith is the use of PEGDA instead of
the conventional EDMA crosslinker, which is believed to result in the high resolution and
sharp peaks obtained for peptide analysis. Due to the hydrophobicity of the AMPS
monomer, a better monolith could be obtained if a more hydrophilic functional monomer
was used. For example, if acrylamido methanesulfonic acid or 2-acrylamido-1ethanesulfonic acid was used in place of AMPS, the hydrophobicity of the resulting
monolith would be dramatically decreased. This should, in turn, provide even better
separation of peptides and make efficient SCX of proteins possible with aqueous buffers
containing no acetonitrile. Unfortunately, neither of the two monomers is commercially
available. I am currently investigating their synthesis.
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CHAPTER 4 POLYMER MONOLITHS WITH LOW HYDROPHOBICITY FOR
STRONG CATION-EXCHANGE CAPILLARY LIQUID CHROMATOGRAPHY
OF PEPTIDES AND PROTEINS

4.1 Introduction
High performance liquid chromatography has grown in importance for proteomics
research due to its high resolving power, excellent reproducibility and ease of interfacing
with mass spectrometry.1 Because of the extreme complexities of peptide mixtures in
“shotgun” proteomics,2 orthogonal two-dimensional (2-D) liquid chromatography is
required for which overall peak capacity is the product of the peak capacities of each
dimension. The most widely used 2-D liquid chromatography combination is ionexchange chromatography [especially strong cation-exchange chromatography (SCX)]
followed by reversed-phase (RP) chromatography.3,4 For this combination, it is important
to use a hydrophilic SCX column that possesses negligible mixed-mode (i.e., ionexchange and hydrophobic interaction) retention of peptides. Otherwise, the resultant 2-D
liquid chromatography is not strictly orthogonal and the final overall peak capacity is
compromised. In the worst case, some very hydrophobic peptides will not elute from the
first dimension SCX column. Currently, the Polysulfoethyl A stationary phase, which
was developed in the late 1980s,5-7 is used most widely for SCX chromatography of
peptides. However, although relatively hydrophilic, the Polysulfoethyl A column has
been found to exhibit some hydrophobicity, and 15-25% acetonitrile is required to
suppress hydrophobic interactions to improve both peptide peak shapes and resolution.5-7
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Polymer monoliths that have comparable chromatographic performance to
particle packed columns were introduced in approximately 1990.8,9 To date, a variety of
polymer monoliths with a broad range of surface chemistries have been introduced for
use in liquid chromatography (please refer to Chapter 1 for detailed review).8-15 In
contrast to monomers used for preparation of polymer monoliths, the number of
crosslinkers is much more limited. Very little effort has been directed toward study of
crosslinker effects on chromatographic performance. This is quite surprising since the
crosslinker is an integral part of the resulting monolith, typically accounting for 30-70%
by weight. As a result, the crosslinker should be expected to significantly affect both the
rigidity of the resulting monolith and its overall polarity.
Lee’s group was the first to use polyethylene glycol diacrylate (PEGDA) as a
biocompatible crosslinker to synthesize an inert polymer monolith for the analysis of
peptides and proteins (see Chapter 2).16 A polyethylene glycol methacrylate-based
crosslinker has also been used to prepare RP monolithic columns.17 The biocompatibility
of PEGDA is mainly a result of the PEG segment in the molecule. PEG is a well known
material that can effectively resist the adsorption of biomolecules,18,19 and has found
application in various fields related to protein resistance.20-23
Using PEGDA as crosslinker, I recently prepared an SCX polymer monolith for
capillary liquid chromatography of peptides (see Chapter 3).24 Using simple one-step
copolymerization of 2-acrylamido-2-methyl-1-propane sulfonic acid (AMPS) and
PEGDA, the resulting monolith provided extremely narrow peaks and high peak
capacity. Although not completely understood, the extraordinary chromatographic
performance is believed to be related to the use of the biocompatible crosslinker PEGDA.
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In addition, it was demonstrated that excessive swelling could be avoided by using a high
percentage (60 wt%) of crosslinker.
Although quite successful, an obvious drawback of the poly(AMPS-co-PEGDA)
monolith is its relatively strong hydrophobicity, i.e., 40% acetonitrile is required to
suppress hydrophobic interactions with hydrophobic peptides. I believe that the
hydrophobicity mainly comes from the AMPS monomer because it has a 4-carbon moiety
(C4) in the molecule (see the structure of AMPS, Figure 4.1).
In an attempt to decrease the hydrophobicity of the poly(AMPS-co-PEGDA)
monolith, two other commercially available sulfonic acid-containing monomers,
sulfoethyl methacrylate (SEMA) and vinyl sulfonic acid (VS), were investigated to
prepare SCX monoliths. It was hoped that by decreasing the hydrocarbon character of the
group that linked the sulfonic acid functionality and the acrylate or vinyl group, a
monolith with decreased hydrophobicity would result. The final goal of this study was to
apply the more hydrophilic monoliths to the resolution of various proteins, including
lipoproteins.

4.2 Experimental Section
4.2.1

Chemicals and Reagents
2,2-dimethoxy-2-phenylacetophenone (99%), 3-(trimethoxysilyl)propyl

methacrylate (98%), and PEGDA (Mn ~258) were purchased from Sigma-Aldrich
(Milwaukee, WI) and used as received. SEMA was obtained from Polysciences
(Warrington, PA), and VS (sodium salt, 30% aqueous solution) was purchased from
Sigma-Aldrich. Both of the monomers were used without further purification. Porogenic
solvents for monolith
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Figure 4.1. Chemical structures of PEGDA crosslinker and several sulfonic acidcontaining monomers.
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synthesis and chemicals for mobile phase buffer preparation were HPLC or analytical
reagent grade.
Bradykinin fragment 1-7 and proteins (myoglobin from equine skeletal muscle,
cytochrome c from bovine heart, α-chymotrypsinogen A from bovine pancreas and
lysozyme from chicken egg white) were obtained from Sigma-Aldrich. Synthetic peptide
standard CES-P0050 was purchased from Alberta Peptides Institute (Edmonton, Alberta,
Canada). High density lipoprotein (HDL) was from Calbiochem (La Jolla, CA).
Ethylenediaminetetraacetic acid (EDTA, disodium salt, dihydrate, ultrapure grade) was
provided by Invitrogen (Carlsbad, CA).

4.2.2

Polymer Monolith Preparation
UV transparent fused silica capillary tubing (75 µm i.d., 375 µm o.d., Polymicro

Technologies, Phoenix, AZ) was silanized with TPM to provide a pendant vinyl group
for anchoring of polymer monoliths following a procedure developed by Vidič et al.25
with slight modifications. Briefly, a 5 m long capillary was rinsed sequentially with
ethanol and water. The capillary was then filled with 2 M HCl, and heated at 110 oC for 3
h in a GC oven with both ends sealed with a union (Upchurch, Oak Harbor, WA). After
surface activation, the capillary was rinsed again with water and ethanol, and dried at 120
o

C for 1 h under a nitrogen gas purge. Silanization of the surface-activated capillary was

performed with 15% (v/v) TPM in dry toluene at 35 oC overnight. After silanization, the
capillary was washed with toluene and acetone sequentially, and then dried under a
nitrogen gas purge at room temperature overnight. Both ends of the silanized capillary
were sealed with rubber septa until further use.
Monomer solutions (see Table 4.1 for reagent composition) were prepared in
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Table 4.1. Reagents and dynamic binding capacities of poly(AMPS), poly(SEMA) and poly(VS) monoliths.
Reagent
PEGDA
Water
(g)
(g)

Ethyl ether UV time
(min)
(g)

DMPA
(g)

Monomer
(g)

AMPSb

0.008

0.32

0.48

0.20

0.55

1.70

3

157

332

SEMA

0.008

0.32

0.48

/

/

0.80

30

62

8

VS

0.0008

1.07c

0.48

/

0.75

/

3

11

32

a

Methanol
(g)

Dynamic binding capacitya
Peptide
Protein
(mg/mL)
(µequiv/mL)

Dynamic binding capacity was measured based on the uptake of bradykinin fragment 1-7 (peptide) or cytochrome c (protein). For

experimental conditions, please refer to Section 3.2.3. b The reagents and dynamic binding capacity for poly(AMPS) monolith are
from Sections 3.2.2 and 3.3.4, respectively. c The VS monomer is a 30 wt% water solution.
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1-dram (4 mL) glass vials by admixing initiator, monomer, crosslinker and porogens. The
monomer solutions were ultrasonicated for 10 s, introduced into the surface silanized
capillary by capillary action, and irradiated for a certain amount of time using a UV
curing system reported in Section 3.2.2. After the monoliths were prepared, they were
connected to an HPLC pump and flushed with methanol and water to remove porogens
and any unreacted monomers. Scanning electron micrographs (SEM) of the monoliths
were obtained as previously described in Section 3.2.2.

4.2.3

Capillary Liquid Chromatography (CLC)
The CLC system used in this study was described in detail in Section 3.2.3. To

decrease the system delay time and set the split ratio to ~1:1000, the splitter capillary was
changed to 40 cm long × 30 µm i.d., and the original stainless steel tubing (100 cm long ×
1/32 inch o.d. × 200 µm i.d.) from the mobile phase mixer was replaced with an open
tubular capillary (70 cm long × 360 µm o.d. × 75 µm i.d.). The chromatographic
conditions are given in the figure captions. The dynamic binding capacities of the test
peptides and proteins were measured, following exactly the procedure previously
described in Section 3.2.3.
Safety Considerations. The SEMA and VS monomers, and the PEGDA

crosslinker are sensitizing agents. Appropriate MSDS information should be consulted
for handling of these materials. Sunglasses that block UV light and gloves should be
worn to avoid burns caused by the high-power UV-curing system during the preparation
of the monoliths.
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4.3 Results and Discussion
4.3.1

Preparation of Polymer Monoliths
The proper selection of porogen is of paramount importance in the preparation of

a monolith for use in chromatography. Because PEGDA was used as crosslinker and
sulfonic acid-containing monomers similar to AMPS were used, the initial choice of
porogen was a mixture of water, methanol and ethyl ether as used in Section 3.2.2.
Although polymer monoliths were formed using this recipe, cracks along the axis of the
capillary were observed under an optical microscope. This resulted in monoliths with
extremely low flow resistance and poor column efficiency, because of channeling of the
mobile phase through the cracks in the monolith. New porogens had to be found to
prepare the poly(SEMA) monolith. After extensive screening, a binary porogen
composed of ethyl ether and hexanes yielded monoliths that were macroscopically
uniform and possessed very low flow resistance. Further optimization, however, revealed
that ethyl ether was unnecessary to be included as a coporogen. The optimized reagent
composition for the poly(SEMA) monolith is given in Table 4.1. Figure 4.2 shows an
SEM image of the poly(SEMA) monolith. The monolith was attached to the capillary
wall, and no cracks were observed. A morphology typical to conventional
polymethacrylate monoliths was obtained.
The preparation of the poly(VS) monolith was originally thought to be somewhat
challenging because the VS monomer could only be obtained as a 30 wt% water solution
and not in the neat form. This introduced the requirement that water must be included in
the monolith recipe and the weight ratio between VS and water had to be equal to (no
addition of water) or less than 3/7 (with addition of water). Fortunately, the preparation of
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A

B

C
C

D

Figure 4.2. SEM images of poly(SEMA) and poly(VS) monoliths. (A) poly(SEMA)
monolith (scale bar = 20 µm); (B) higher magnification of the monolith in (A) (scale bar
= 2 µm); (C) poly(VS) monolith (scale bar = 20 µm); (D) higher magnification of the
monolith in (C) (scale bar = 2 µm).
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the poly(VS) monolith was far less difficult than anticipated. A combination of water and
methanol was found effective in generating a stable flow-through monolith. The
optimized reagent composition is listed in Table 4.1. SEM of the optimized poly(VS)
monolith (Figure 4.2C-D) revealed a different morphology compared to the poly(SEMA)
monolith, but a similar morphology to the poly(AMPS) monolith.

4.3.2

Hydrophobicity of the Poly(SEMA) Monolith
Four synthetic undecapeptides (see Table 3.1) were used to determine the

hydrophobicity of the poly(SEMA) and poly(VS) monoliths. Figure 4.3 shows a gradient
elution separation of the four synthetic peptides using buffers that contain different
amounts of acetonitrile. For the most hydrophobic peptide 4 with hydrophobicity index
24.2 at pH 2.0,24 40% acetonitrile was required to suppress the hydrophobic interaction
between the monolith and the peptide. For the other three peptides, there was negligible
difference between the elution patterns between 0% to 20% acetonitrile additives.
However, when higher concentrations of acetonitrile (e.g., 30 or 40%) were used in the
mobile phase, narrower peaks were observed. In general, the elution pattern of the four
synthetic peptides using poly(SEMA) were similar to that of the poly(AMPS) monolith.
However, much lower column efficiency was observed for the newly prepared
poly(SEMA) monolith, although resolution of the four peptides was acceptable. A peak
capacity of 21 was achieved for the poly(SEMA) column using buffers containing 40%
acetonitrile, in contrast to 71 for the poly(AMPS) monolith.
It is surprising that the hydrophobicity of poly(SEMA) is similar to that of
poly(AMPS) although there is less hydrocarbon character in the SEMA molecule.
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Figure 4.3. SCX chromatography of four synthetic undecapeptides. Conditions: 15 cm ×
75 µm i.d. poly(SEMA) monolithic column; buffer A was 5 mM NaH2PO4 (pH 2.7) and
buffer B was buffer A plus 1.0 (panel A) or 0.5 M NaCl (panels B, C, D and E), both
buffers containing 0, 10, 20, 30, or 40% (v/v) acetonitrile (panels A, B, C, D, and E,
respectively); 2 min isocratic elution of 1% B, followed by a linear AB gradient (5%
B/min for panels B, C, D and E, and 2.5% B/min for panel A) to 100% B and various
times of isocratic elution with 100% B until peptide 4 was eluted; 1.8 min gradient delay
time; mixture of peptides 1-4 (Table 3.1); 12 µL/min pump master flow rate; 510, 460,
440, 440 or 440 nL/min column flow rates (panels A, B, C, D, and E, respectively);
online UV detection at 214 nm.
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Therefore, for overall hydrophobic interaction, other factors must be considered. Due to
the single bond connection to the monolith backbone, the sulfonic acid functional group
would rotate freely into and out of the backbone. In some circumstances, analytes could
directly interact with the backbone of the monolith. Although the contribution to
hydrophobicity by the biocompatible PEGDA crosslinker was found to be insignificant,
the carbon-carbon linkage resulting from polymerization of vinyl groups in the monomer
could lead to some hydrophobic interactions. Thus, the overall hydrophobicity must
result from the sum of the hydrocarbon components of the side chains of the functional
groups and the backbone of the polymer.
The backbone hydrophobicity is mainly determined by the type of vinyl group
and the surface coverage by the functional groups. At present, there is no good
methodology available to directly measure the surface coverage by the functional groups.
One indirect method is to use dynamic binding capacity to estimate the surface coverage.
The dynamic binding capacity of the poly(SEMA) monolith was measured to be 62
µequiv/mL, based on the uptake of bradykinin fragment 1-7 (see Table 3.1). This value is

smaller than that of the poly(AMPS) monolith (157 µequiv/mL), indicating a lower
surface coverage by the sulfonic acid groups; this results in less hydrophobicity.
However, another more important factor that affects the backbone hydrophobicity is the
type of vinyl groups in the monomer. The backbone hydrophobicity of poly(AMPS) is
low because of the use of the biocompatible acrylamido group. As a result, the overall
hydrophobicity of poly(SEMA) (from the C2 sulfonic acid linkage and the backbone) is
comparable to that of poly(AMPS) (mainly from the C4 linkage).
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Although disappointing for decreasing column hydrophobicity, the poly(SEMA)
monolith had very low flow resistance, which made it useful in performing fast
separations. Figure 4.4 shows a separation of the four undecapeptide standards in 5 min
using a fast flow rate (linear velocity of 43 cm/min) and a sharp gradient. The total
analysis time could be further decreased to 2 min by simply using a sharper gradient rate
(50% B/min). However, the peak for peptide 4 became somewhat skewed under these
conditions.

4.3.3

Hydrophobicity of the Poly(VS) Monolith
Figure 4.5 shows the elution of the four synthetic peptides under various

acetonitrile concentrations. It is obvious that the overall hydrophobicity of the poly(VS)
column is much less than either poly(AMPS) or poly(SEMA) monoliths. As is seen in
Figure 4.5A for which no acetonitrile was used, peptide 4 could be eluted in 40 min,
although a tailing peak was observed due to nonspecific hydrophobic adsorption. With an
acetonitrile concentration of 30%, hydrophobic interactions could be suppressed, and
40% acetonitrile narrowed the peptide 4 peak somewhat further. The resolution of
peptides 2 and 3 was improved with the addition of 20% acetonitrile. Although
improvement was made with the addition of acetonitrile, the effect of acetonitrile on the
peak profiles for peptides 2 and 3 was not as dramatic as for either poly(AMPS) or
poly(SEMA) monoliths, indicating decreased hydrophobicity of the poly(VS) monolith.
Peak capacity was increased from 20 (Figure 4.5A) to 27 (Figure 4.5D) with the addition
of 30% acetonitrile compared to no acetonitrile, and decreased to 24 (Figure 4.5E) when
40% acetonitrile was used. Therefore, 20-30% acetonitrile is sufficient to suppress the
hydrophobic interaction of the poly(VS) monolith. The hydrophobicity of the poly(VS)
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Figure 4.4. Fast SCX chromatography of synthetic peptides using a poly(SEMA)
monolithic column. Conditions were the same as in Figure 4.3E except that a faster pump
master flow rate of 48 µL/min, column flow rate of 1.9 µL/min and 20% B/min gradient
rate were used.
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Figure 4.5. SCX chromatography of synthetic peptides using a poly(VS) monolithic
column. Conditions were the same as in Figure 4.3 with the following exceptions: 16 cm
× 75 µm i.d. poly(VS) monolithic column; buffer B in panel A contained 0.5 M NaCl;
pump master flow rate was 24 µL/min; gradient delay time was 8 min; 102, 98, 83, 83 or
78 nL/min column flow rates (panels A, B, C, D, and E, respectively).
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monolith must come from the backbone of the monolith because the VS monomer does
not have any extra carbon atoms in the linking group. While the dynamic binding
capacity of the poly(VS) monolith was smaller than that of the poly(AMPS) monolith,
indicating less hydrophobicity, a significant contribution to column hydrophobicity could
still come from the backbone of the monolith. Although somewhat
hydrophobic, it should be noted that the poly(VS) monolith could elute the most
hydrophobic peptide 4 in relatively short time without the addition of acetonitrile, making
it useful as a first dimension in proteomics studies.
The column stability and reproducibility of the poly(VS) monolith are excellent.
The poly(VS) monolith was continuously used at ~1000 psi head pressure for two months
without deterioration of column performance (i.e., resolution, efficiency and peak shape).
This confirms that it is feasible to prepare a stable SCX monolith by copolymerization of
a sulfonic acid-containing monomer and a crosslinker if high percentage of crosslinker is
used. An evaluation of run-to-run reproducibility with buffers containing 30%
acetonitrile, gave relative standard deviation values (RSD, n = 5) of retention times and
peak heights for the four synthetic peptides of 1.5, 1.0, 0.8, and 0.5, and 2.5, 1.2, 2.0, and
1.6, respectively. Column-to-column reproducibility was also good; the RSDs (n = 3) for
retention times and peak heights were 2.5, 1.4, 1.6, and 3.0, and 2.3, 2.8, 1.6, and 4.0,
respectively.

4.3.4

Strong Cation-Exchange Liquid Chromatography of Proteins
Figure 4.6 shows SCX chromatography of protein standards using the hydrophilic

poly(VS) monolith. Sharp peaks were obtained for all four proteins. Although the
poly(VS) monolith generated lower peak capacity for the four undecapeptides than did
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Figure 4.6. SCX chromatography of proteins. Conditions: 16 cm × 75 µm i.d. poly(VS)
monolithic column; buffer A was 5 mM phosphate (pH 6.2) and buffer B was buffer A
plus 1.0 M NaCl; pump master flow rate, 24 µL/min pump master flow rate; column flow
rate was 104 nL/min; gradient delay time was 8 min; linear gradient from 1% B to 50% B
in 20 min, ramped to 100% B in 2 min and followed by 20 min isocratic run of B;
analytes: (1) 1.14 mg/mL of cytochrome c, (2) 1.60 mg/mL of α-chymotrypsinogen A, (3)
1.10 mg/mL of ribonuclease A and (4) 1.50 mg/mL of lysozyme; the baseline drift during
gradient elution and the rise of the baseline at the end of the gradient were due to the
difference in UV absorbances of buffers A and B.
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Figure 4.7. SCX chromatography of high density lipoprotein. Conditions were the same
as in Figure 4.6 with the following exceptions: buffer A was 10 mM citrate (pH 5.0)
containing 0.01% EDTA, and buffer B was buffer A plus 1.0 M NaCl; 2 min 1% B, 20
min gradient from 1% to 100% B, and 12 min 100% B; analyte: 11 mg/mL HDL; online
UV detection at 214 nm.
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the poly(AMPS) monolith, it yielded better peak profiles for proteins. This indicates that
a polymer monolith with less hydrophobicity was prepared. It also demonstrates that a
monolith with carefully designed hydrophilicity is beneficial for SCX chromatography of
proteins.
The usefulness of the poly(VS) monolith was further demonstrated by SCX
chromatography of hydrophobic proteins. Lipoproteins are important biological
macromolecular complexes of lipids and apolipoproteins which function to transport
lipids in blood.26 Disorders in lipoprotein metabolism are one of the most important risk
factors for the development of coronary heart disease. Because they contain lipids and are
bulky, lipoproteins are very hydrophobic and, thus, difficult to analyze using
conventional SCX columns.27 HDL is a very complex mixture that has been resolved into
12 subclasses using 2-D gel eletrophoresis.28 Using the hydrophilic poly(VS) monolith,
five subclasses of HDL were resolved (Figure 4.7). Further optimization of
chromatographic parameters for this application is underway.

4.4 Conclusions
In this study, I prepared stable SCX monoliths by copolymerizing sulfonic acidcontaining monomers and PEGDA crosslinker. In the design of SCX polymer monoliths
for peptides and proteins, it is important to control the overall hydrophobicity to decrease
nonspecific interactions. The overall hydrophobicity of the monolith can be tuned by the
use of appropriate crosslinkers and monomers. The contribution of hydrophobicity from
the monomer mainly results from the linking group that connects the sulfonic acid
functionality with the polymerization functionality. The type of polymerization
functionality (e.g, vinyl or methacrylate or acrylamido) also results in different backbone
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hydrophobicity. Among the three monomers (AMPS, SEMA and VS) studied, VS
resulted in a monolith with the least hydrophobicity.
Further improvement should be achieved with the use of more suitable monomers.
For example, if acrylamido methanesulfonic acid is used as a functional monomer and
PEGDA as a crosslinker, an SCX monolith with negligible hydrophobicity would be
expected. Although I have already synthesized this monomer, I have not been able to
purify it sufficiently. Another potentially useful monomer would have acrylate or
methacrylate at one end, PEG in the middle, and sulfonic acid at the other end. By using
PEGDA as a crosslinker, an ideal monolith with backbone completely comprised of PEG
and surface comprised of sulfonic acid would be obtained. Detailed description of the
improvement in hydrophilicity of SCX monoliths is provided in Chapter 5.
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CHAPTER 5 FUTURE DIRECTIONS

5.1 Optimization of Pore Volume Distribution of the Poly(PEGMEA-co-PEGDA)
Monolith for SEC of Proteins
To date, only two reports have been found for preparing polymer monolithic SEC
columns.1,2 The first report was based on poly(styrene-co-divinylbenzene) prepared via
stable free radical initiation.1 Although the monolith possessed relatively broad pore
volume distribution, the separation of model linear polystyrene standards (Molecular
masses of 3,200,000, 210,500 and 580) indicated that column efficiency was too low to
achieve moderate resolution. Only marginal separation was achieved for SEC of the three
polystyrenes. Another potential problem is the use of very hydrophobic polystyrene
chemistry. Although surface modification of the polystyrene could render it somewhat
hydrophilic, it is very difficult to completely modify the surface via on-column
modification. As a result, it is very challenging to perform SEC of proteins using this
type of chemistry.
Lubbad et al. used the ROMP method to prepare a polynorbornene monolith for
SEC of synthetic polymers.2 By using a mixture of suitable crosslinkers, a monolith,
which possesses both good mechanical strength and, more importantly, continuous pore
size distribution, was obtained. Due to the hydrophobic nature of polynorbornene, the
monolith was evaluated for SEC of polystyrene standards. Although the monolith was
used for fast separation, resolution of standard polystyrenes was still insufficient, as
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observed from overlay of chromatograms of several polystyrene standards. The
norbornene-based monolith has the same limitation as the polystyrene-based monolith for
aqueous SEC of proteins, as described in the previous paragraph.
There is clearly a need to develop novel polymer monoliths for aqueous SEC of
proteins. In Chapter 2, an inert poly(PEGMEA-co-PEGDA) monolith that exhibited
negligible hydrophobic and ionic interactions with proteins was successfully developed.
The monolith was applied to SEC of peptides. However, no separation of globular
proteins in the molecular weight range of 10-100 kDa was observed. Inverse size
exclusion chromatography with the monolith revealed that the mesopore volume, which
determines the resolution of proteins, accounted for only 4.2% of the total pore volume,
while most of the pore volume was contributed from the macropores (77.8%) and
micropores (10.9%). Because of the 10.9% micropore volume, separation of peptides was
achieved. Thus, for SEC of proteins using this type of inert monolith, a mesopore volume
of at least 10% must be obtained. It is also well known that the efficiency in SEC is much
lower for macromolecules (e.g., proteins) than small molecules (e.g., peptides) due to the
smaller diffusion coefficients of macromolecules.3 This implies that a mesopore volume
much greater than 10% would be required to effectively separate proteins. It would be
desirable if a mesopore volume >20% was obtained.
I propose to synthesize polymer monoliths for aqueous SEC of proteins using the
inert PEGMEA chemistry. Two approaches will be explored to optimize the mesopore
volume. The first is to use a template in the porogen design. I plan to investigate PEG as
a porogen for the preparation of a poly(PEGMEA-co-PEGDA) monolith. PEG has been
used as porogen or coporogen for the preparation of other polymer monoliths.4,5 However,
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in these two examples, the reasons for using PEG as a porogen were mainly to adjust the
through-pore diameter and to control the surface hydrophilicity. The PEG I plan to use is
intended to control the mesopore volume. During the formation of the polymer monolith,
portions of the porogen will be trapped inside globules and between globules. After
polymerization and flushing, the porogen will be washed out, leaving the desirable pores.
By choosing a suitable chain length of PEG porogen, which has a Stokes’s diameter that
is comparable to the diameters of globular proteins, monoliths with templated porous
structure will be obtained. My preliminary results show that PEG (Mw of 3300) is a very
promising porogen to provide a monolith with large number of mesopores. SEC of two
model proteins, bovine serum albumin and thyroglobulin, was recently obtained (data not
shown). Although not baseline separated, this demonstrates the potential of using PEG to
engineer the pore volume distribution. Further optimization (e.g., adjusting the ratio
between PEG and coporogen, tuning the ratio between total monomer to total porogen,
and increasing the column diameter and length) will improve the SEC separation.
The other approach to adjust the mesopore volume is to increase the crosslinker to
monomer ratio in the monolith recipe. Based on a related study involving solid phase
extraction using a poly(styrene-co-divinylbenzene) monolith, a significant increase in
surface area was obtained if the divinylbenzene crosslinker to styrene monomer ratio was
increased.6 The surface area of typical polymer monoliths is in the range of 1-20 m2/g. By
using 80 wt% of divinylbenzene in the recipe, a monolith with surface area as high as 400
m2/g was obtained.6 This increase in surface area indicates an increase in micro and/or
mesopore volume. I plan to greatly increase the PEGDA ratio in the poly(PEGMEA-coPEGDA) monolith recipe for increasing the mesopore volume. It is likely that a
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combination of both approaches proposed in this dissertation will ultimately result in a
highly original polymer monolith that can be used for fast, efficient and high resolution
of proteins in the SEC mode.

5.2 Further Improvement in SCX Monolith Hydrophilicity
In Chapters 3 and 4, three polymer monoliths were prepared and used for SCX
chromatography of peptides and proteins. The poly(AMPS) monolith generated the
highest resolution and peak capacity for the analysis of peptides. However, it was not
well suited for protein analysis due to its strong hydrophobicity. The poly(SEMA)
monolith surprisingly possessed the same strong hydrophobicity as poly(AMPS). An
attractive feature, however, was the low flow resistance, making it possible to perform
fast SCX chromatography of peptides. The least hydrophobic monolith was obtained
when VS was used as the functional monomer. The poly(VS) monolith was useful for
SCX chromatography of both peptides and proteins including lipoproteins. Although
relatively hydrophilic, the poly(VS) monolith still possessed some hydrophobicity, i.e.,
20-30% acetonitrile was required to suppress hydrophobic interactions for highly
hydrophobic peptides.
Clearly, a further decrease in hydrophobicity will result in a better SCX monolith
for the analysis of biological analytes. This can be achieved by designing and using more
suitable monomers. I propose to use two types of monomers to achieve this goal. The
first monomer will be acrylamidosulfonic acid or acrylamidomethane sulfonic acid
(Figure 5.1). These two monomers, analogs to AMPS, have shorter linking groups
between the acrylamido and sulfonic acid functionalities. According to the studies
described in Chapters 3 and 4, the hydrophobicities of monoliths prepared from such
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Figure 5.1. Chemical structure of the proposed monomers.
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Figure 5.2. Scheme for the synthesis of acrylamidomethane sulfonic acid.
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monomers will be greatly decreased. A similar porogen system (e.g., water, methanol,
ethyl ether and hexanes) will be used to synthesize the monolith. A challenging task,
however, will be the synthesis of such monomers. I plan to use acryloyl chloride and
sulfamic acid or aminomethylsulfonic acid as reactants (Figure 5.2). Preliminary results
indicate that acrylamidomethane sulfonic acid can be synthesized. I plan to purify the
product (monomer) from reactants by using preparative ion exchange chromatography.
Another type of monomer that could be potentially useful for preparing SCX
monolith with negligible hydrophobicility is shown in Figure 5.3. Because the
poly(PEGMEA-co-PEGDA) monolith has proven to be an inert monolith for proteins
(Chapter 2), the monomer I propose here will provide a monolith that has negligible
hydrophobicity. This will in turn result in one of the best SCX polymer monoliths for
biological compound analysis.

5.3 Preparation of Anion-exchange Polymer Monoliths Using PEGDA as
Crosslinker
With the recent successful development of SCX monoliths, future efforts will be
naturally directed towards the synthesis of anion-exchange monoliths. Once again, I will
use the biocompatible PEGDA crosslinker to decrease backbone nonspecific hydrophobic
interactions during the anion-exchange process. Both direct copolymerization and surface
derivatization approaches will be explored to introduce the amine functionality (Figure
5.4).
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Figure 5.4. Approaches for the preparation of anion-exchange monoliths.

146

In the derivatization approach, a poly(GMA) monolith using PEGDA as
crosslinker will be prepared first, followed by chemical modification with diethylamine
to provide the desirable weak anion-exchange monolith. Alternatively, direct
copolymerization of amine-containing functional monomers such as DEAEM or AETC
with PEGDA will yield monoliths with weak and strong anion-exchange functionalities,
respectively. A systematic study will be performed to evaluate the different approaches
for the preparation of anion-exchange monoliths using model acidic protein standards
such as myoglobin, conalbumin, ovalbumin and soybean trypsin inhibitor. My
preliminary results indicate that the poly(AETC) monolith had the least hydrophobicity
and exhibited the highest column efficiency. Application of the poly(AETC) monolith to
lipoproteins gave very encouraging results; 12 subclasses of high density lipoproteins
were resolved using simple gradient elution anion-exchange chromatography. I will
optimize the synthesis variables and chromatographic parameters for improvements in
both mechanical stability and chromatographic performance.

5.4 Preparation of Other Types of Polymer Monoliths Using PEGDA as
Crosslinker
It will be straightforward to prepare a monolith using PEGDA as crosslinker for
use in hydrophobic interaction chromatography. This can be easily achieved by using a
large amount of PEGDA and a small amount of hydrophobic monomer (e.g., butyl
acrylate) in the monolith recipe. The resulting monolith will have a hydrophobicity that is
small enough to retain proteins only under high concentration of sodium sulfate. As a
result, separation will be guided by the hydrophobic interaction chromatography
mechanism. On the other hand, a reversed-phase monolith could be prepared if I use a
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large percentage of hydrophobic monomers and a small portion of PEGDA in the
monolith recipe. Considering the lack of good polymethacrylate or polyacrylate
monoliths for use in reversed-phase capillary LC of proteins or peptides,7 my aim is to
prepare a RP monolith that has very good chromatographic performance, comparable to
the well developed polystyrene-based monolith. This ambitious goal could be achieved
through optimization of the synthesis recipe. A porogen that can provide abundant
mesopores will be useful to achieve such a goal because mass transfer resistance is much
smaller in mesopores than in micrpores in the monolith. PEG holds promise as a porogen
for such purposes.
In chiral separation, nonspecific hydrophobic and/or ionic interactions are
detrimental. Chiral stationary phases mainly include three types: three-point interaction,
protein, and cavity phases.8,9 The most popular stationary phase is the three-point
interaction type. Any chemicals that possess the required chiral recognition capability and
have polymerizable vinyl groups could be potentially copolymerized with PEGDA to
yield chiral monoliths. With the use of the biocompatible PEGDA crosslinker, I hope that
significant advances in chiral polymer monolithic stationary phases will be obtained.
Finally, the PEGDA crosslinker is also suitable for preparation of affinity
monoliths. For example, poly(GMA), a widely used monolith, is often used as a base
material for immobilizing affinity ligands. By using PEGDA to replace conventional
EDMA or TRIM crosslinkers, nonspecific binding from the backbone will be decreased.

5.5 Application of PEGacrylate-based Monoliths to Proteomics Research
The application of polymer monoliths in proteomic research is scarce, compared
with packed columns. With the recent commercialization of capillary polystyrene and
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polymethacrylate monoliths, more applications should appear in the future. My approach
of using a biocompatible PEGDA crosslinker has led to the development of efficient SEC
and SCX capillary monolithic columns. The proposed work described in Sections 5.1-5.4
will enable the development of other novel and efficient monoliths that can be used in a
variety of chromatographic modes. This opens the possibility to use PEG acrylate-based
monolithic capillary columns for 2-D LC of proteins, currently the most promising
method for proteomics research.
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